WO2016038143A1

WO2016038143A1 - Microbiocidal 4-(imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3- amine compounds having an oxime group in position 7

Info

Publication number: WO2016038143A1
Application number: PCT/EP2015/070726
Authority: WO
Inventors: Jayant Umarye; Martin Pouliot
Original assignee: Syngenta Participations Ag
Priority date: 2014-09-12
Filing date: 2015-09-10
Publication date: 2016-03-17

Abstract

The present invention provides compounds of formula (I) wherein Y¹, Y², Υ³, Υ⁴ and Υ⁵ are as defined in the claims. The invention further relates to compositions which comprise these compounds and to their use in agriculture or horticulture for controlling or preventing infestation of plants by phytopathogenic microorganisms, preferably fungi.

Description

MICROBIOCIDAL 4-(IMIDAZO[4,5-C]PYRIDIN-2-YL)-1 ,2,5-OXADIAZOL-3- AMINE COMPOUNDS HAVING AN OXIME

GROUP IN POSITION 7

The present invention relates to novel microbiocidally active, in particular fungicidally active, imidazopyridine derivatives. It further relates to intermediates used in the preparation of these compounds, to compositions which comprise these compounds and to their use in agriculture or horticulture for controlling or preventing infestation of plants by phytopathogenic microorganisms, 5 preferably fungi.

The application WO2009000413 is in the pharmaceutical field and is related to substituted benzoimidazoles, their preparation and their use for inducing apoptosis.

Surprisingly, it has been found that novel compounds have microbiocidal activity.

The present invention accordingly relates to oxime derivatives of formula (I)

wherein

Y represents Ci-C₆ alkyl, C₃-C₈ cycloalkyi, C₂-C₆ alkenyl, C₃-C₆ alkynyl or OR¹ , wherein the alkyl, cycloalkyi, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹ , C_rC₄ alkyl, C_rC₄ haloalkyl, C₃-C₈ cycloalkyi,

15 C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, C1-C4 alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y² represents hydrogen, Ci-C₆ alkyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C0₂R¹ , CON(R³)₂, phenyl, 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, Ci-C₆ alkyl substituted by phenyl, Ci-C₆ alkyl substituted by 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S

20 and N, OR¹, Ci-C₆ alkylthio, N(R³)₂ or NR³COR², wherein the alkyl, cycloalkyi, cycloalkenyl, alkenyl, alkynyl, phenyl, and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹, C C₄ alkyl, C C₄ haloalkyl, C C₄ alkylthio, C C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y³ represents hydrogen, Ci-C₆ alkyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl, C₂-C₆

25 alkynyl, phenyl, naphthyl, 5- to 10- membered mono- or bicyclic heterocycle containing one to three

heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, Ci-C₆ alkyl substituted by phenyl, Ci-C₆ alkyl substituted by 5- or 10- membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, C0₂R¹ , COR² or CON(R³)₂,

30 wherein the alkyl , cycloalkyi, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl, naphthyl, and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², SH, N0₂, OR¹ , d-d alkyl, d-d haloalkyl, phenyl, halophenyl, d-d alkylphenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C1-C4 alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y⁴ represents hydrogen, halogen, CN, Ci-C₆ alkyl, C₃-C₈ cycloalkyl, C₂-C₆ alkenyl, C₃-C₆ alkynyl, Ci-C₆ alkylthio, OR¹ , C0₂R¹ or CON(R³)₂, wherein the alkyl, cycloalkyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹ , d-d alkyl, d-d haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d-d alkylthio, d- d alkylsulphinyl and d-d alkylsulphonyl;

Y⁵ represents hydrogen, halogen, CN, d-C₆ alkyl, C₃-C₈ cycloalkyl, C₂-C₆ alkenyl, C₃-C₆ alkynyl, d-C₆ alkylthio, OR¹ , C0₂R¹ or CON(R³)₂, wherein the alkyl, cycloalkyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂,

NR³COR², OR¹ , d-d alkyl, d-C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d-C₄ alkylthio, d- C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

each R is independently selected from hydrogen, d-C₆ alkyl, C₃-C₈ cycloalkyl, Ci-C₂ alkyl substituted by C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, phenyl, benzyl, a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R³) and Ci-C₂ alkyl substituted by a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R³), wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, Ci-C₄ alkyl, Ci-C₄ haloalkyl, Ci-C₄ alkoxy, Ci-C₄ haloalkoxy, Ci-C₄-alkoxy-Ci-C₄-alkyl and Ci-C₄ alkoxycarbonyl;

each R² is independently selected from hydrogen, d-C₆ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₈ alkenyl, C₂-C₈ alkynyl, phenyl, benzyl and pyridyl, wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and pyridyl groups are optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, Ci-C₄ alkyl, Ci-C₄ haloalkyl, d-C₄ alkoxy, Ci-C₄ alkylthio and Ci-C₄ haloalkoxy;

each R³ is independently selected from hydrogen, d-C₆ alkyl, C₃-C₆ alkenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₆ alkynyl, phenyl, benzyl, CN, OR¹ , COR², d-C₆ alkylsulphonyl and a 5- or 6- membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R⁸), wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, d-C₄ alkyl, Ci-C₄-haloalkyl, Ci-C₄ alkoxy, Ci-C₄ haloalkoxy and Ci-C₄-alkoxy-Ci-C₄-alkyl;

wherein when two radicals R³ are attached to the same nitrogen atom, these radicals can be identical or different;

wherein when two radicals R³ are attached to the same nitrogen atom, both of these radicals cannot be OR¹ ;

and wherein when two radicals R³ are attached to the same nitrogen atom, these two radicals together with the nitrogen atom to which they are attached may form a heterocycle, wherein the heterocycle formed is optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, d-C₄ alkyl, d-C₄ haloalkyl, d-C₄ alkoxy and d-C₄ haloalkoxy; each R is independently selected from hydrogen, Ci-C₆ alkyl, Ci-C₆ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl and Ci-C₆ alkoxy-Ci-C₆ alkyl;

or agriculturally acceptable tautomers, salts or N-oxides thereof.

Halogen, either as a lone substituent or in combination with another substituent (e.g. haloalkyl) is generally fluorine, chlorine, bromine or iodine, and usually fluorine, chlorine or bromine.

Each alkyl moiety (including the alkyl moiety of alkoxy, alkylthio, etc.) is a straight or branched chain and, depending on the number of carbon atoms it contains, is, for example, methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, /^'so-propyl, sec-butyl, /^'so-butyl, ieri-butyl, neo-pentyl, n-heptyl or 1 ,3-dimethylbutyl, and usually methyl or ethyl.

The alkenyl and alkynyl groups can be mono- or di-unsatu rated and examples thereof are derived from the above mentioned alkyl groups.

The alkenyl group is an unsaturated straight or branched chain having a carbon-carbon double bond and, depending on the number of carbon atoms it contains, is, for example ethenyl, 1-propenyl, 2-propenyl, 1-methyl-ethenyl, 1 -butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1- propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1 -butenyl, 2- methyl-1 -butenyl, 3-methyl-1 -butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1- methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1 , 1-dimethyl-2-propenyl, 1 ,2-dimethyl-1- propenyl, 1 ,2-dimethyl-2-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5- hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1- methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3- pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2- methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1 , 1-dimethyl-2-butenyl, 1 ,1-dimethyl-3- butenyl, 1 ,2-dimethyl-1 -butenyl, 1 ,2-dimethyl-2-butenyl, 1 ,2-dimethyl-3-butenyl, 1 ,3-dimethyl-1 -butenyl, 1 ,3-dimethyl-2-butenyl, 1 ,3-dimethyl-3-butenyl, and usually 2-propenyl, 1-methyl-2-propenyl, 2- butenyl, 2-methyl-2-propenyl.

The alkynyl group is an unsaturated straight or branched chain having a carbon-carbon triple bond and, depending on the number of carbon atoms it contains, is, for example ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4- pentynyl, 3-methyl-1-butynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 1 , 1-dimethyl- 2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 3-methyl-1- pentynyl, 4-methyl-1 -pentynyl, 1-methyl-2-pentynyl, 4-methyl-2-pentynyl, 1-methyl-3-pentynyl, 2- methyl-3-pentynyl, 1-methyl-4-pentynyl, 2-methyl-4-pentynyl, 3-methyl-4-pentynyl, 3,3,-dimethyl-1- butynyl, 1-ethyl-2-butynyl, 1 , 1-dimethyl-2-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl, 1 , 1-dimethyl-3- butynyl, 2,2-dimethyl-3-butynyl, 1 ,2-dimethyl-3-butynyl.

Haloalkyl moieties are alkyl moieties which are substituted by one or more of the same or different halogen atoms and are, for example, monofluoromethyl, difluoromethyl, trifluoromethyl, monochloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2,2-difluoroethyl, 2-fluoroethyl, 1 , 1-difluoroethyl, 1-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1 , 1-difluoro-2,2,2-trichloroethyl, 2,2,3,3- tetrafluoroethyl and 2,2,2-trichloroethyl, and typically trichloromethyl, difluorochloromethyl, difluoromethyl, trifluoromethyl and dichlorofluoromethyl. Alkoxy is, for example, methoxy, ethoxy, propoxy, /^'so-propoxy, n-butoxy, /^'so-butoxy, sec-butoxy and ieri-butoxy, and usually methoxy or ethoxy.

Haloalkoxy is, for example, fluoromethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoro- ethoxy, 1 ,1 ,2,2-tetrafluoroethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2,2-difluoroethoxy and 2,2,2- trichloroethoxy, and usually difluoromethoxy, 2-chloroethoxy and trifluoromethoxy.

Alkylthio is, for example, methylthio, ethylthio, propylthio, /^'so-propylthio, n-butylthio, iso- butylthio, sec-butylthio or ieri-butylthio, and usually methylthio or ethylthio.

Alkylsulphonyl is, for example, methylsulphonyl, ethylsulphonyl, propylsulphonyl, iso- propylsulphonyl, n-butylsulphonyl, /^'so-butylsulphonyl, sec-butylsulphonyl or ieri-butylsulphonyl, and usually methylsulphonyl or ethylsulphonyl.

Alkylsulphinyl is, for example, methylsulphinyl, ethylsulphinyl, propylsulphinyl, iso- propylsulphinyl, n-butylsulphinyl, /^'so-butylsulphinyl, sec-butylsulphinyl or ieri-butylsulphinyl, and usually methylsulphinyl or ethylsulphinyl.

Cycloalkyl may be saturated or partially unsaturated, preferably fully saturated, and is, for example, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.

Alkoxyalkyl is, for example, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, n- propoxymethyl, n-propoxyethyl, /so-propoxymethyl or /^'so-propoxyethyl.

Aryl includes phenyl, naphthyl, anthracyl, fluorenyl and indanyl, but is usually phenyl.

Carbocycle includes cycloalkyl groups and aryl groups.

Heterocycloalkyi is a non-aromatic ring that may be saturated or partially unsaturated, preferably fully saturated, containing carbon atoms as ring members and at least one heteroatom selected from O, S and N as ring members. Examples include oxiranyl, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, 1 ,3-dioxolanyl, 1 ,4-dioxanyl, aziridinyl, azetidinyl, pyrrolidinyl, piperidinyl, oxazinanyl, morpholinyl, thiomorpholinyl, imidazolidinyl, pyrazolidinyl and piperazinyl, preferably morpholinyl, pyrrolidinyl, piperdinyl and piperazinyl, more preferably morpholinyl and pyrollidinyl.

Heteroaryl is, for example, a monovalent monocyclic or bicyclic aromatic hydrocarbon radical. Examples of monocyclic groups include pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, furanyl, thiophenyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, isothiazolyl, and thiadiazolyl. Examples of bicyclic groups include quinolinyl, cinnolinyl, quinoxalinyl, benzimidazolyl, benzothiophenyl, and benzothiadiazolyl. Monocyclic heteroaryl groups are preferred, preferably pyridyl, pyrrolyl, imidazolyl and triazolyl, e.g. 1 ,2,4 triazolyl, pyridyl and imidazolyl being most preferred.

The terms "heterocycle" and "heterocyclic ring" are used interchangeably and are defined to include heterocycloalkyi and heteroaryl groups. Any reference herein to a heterocycle or heterocyclic ring preferably refers to the specific examples given under the definition of heteroaryl and heterocycloalkyi above, and are preferably morpholinyl, pyrrolidinyl, piperdinyl, piperazinyl pyridyl, pyrrolyl, imidazolyl and triazolyl, e.g. 1 ,2,4 triazolyl, more preferably morpholinyl, pyrollidinyl, pyridyl and imidazolyl. No heterocycle contains adjacent oxygen atoms, adjacent sulphur atoms, or adjacent oxygen and sulphur atoms. Where a moiety is indicated as being (optionally) substituted, e.g. alkyl, this includes those moieties where they are part of a larger group, e.g. the alkyl in the alkylthio group. The same applies, e.g. to the phenyl moiety in phenylthio etc. Where a moiety is indicated as being optionally substituted by one or more other groups, preferably there are one to five optional substituents, more preferably one to three optional substituents. Where a moiety is substituted by a cyclic group, e.g. aryl, heteroaryl, cycloalkyl, preferably there are no more than two such substituents, more preferably no more than one such substituent.

The following substituents definitions, including preferred definitions, may be combined in any combination:

Y represents Ci-C₆ alkyl, C₃-C₈ cycloalkyl, C₂-C₆ alkenyl, C₃-C₆ alkynyl or OR¹, wherein the alkyl, cycloalkyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹, d-d alkyl, d-d haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, C1-C4 alkylsulphinyl and Ci-C₄ alkylsulphonyl.

Preferably, Y represents Ci-C₆ alkyl, C₂-C₆ alkenyl, C₃-C₆ alkynyl or OR¹, wherein the alkyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, NR³COR², OR¹, d-d alkyl, d-d haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d-d alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl.

More preferably, Y represents Ci-C₆ alkyl, C₂-C₆ alkenyl, C₃-C₆ alkynyl or OR¹, wherein the alkyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, Ci-C₄ alkyl, Ci-C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl and Ci-C₄ alkylthio.

Even more preferably, Y represents Ci-C₆ alkyl or OR¹, wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, Ci-C₄ alkyl, Ci-C₄ haloalkyl, C₃-C₈ cycloalkyl and C₃-C₈ cycloalkenyl.

Most preferably, Y represents Ci-C₄ alkyl optionally substituted by one or more groups independently selected from halogen, Ci-C₂ alkyl, Ci-C₂ haloalkyl and C₃-C₆ cycloalkyl.

Y² represents hydrogen, Ci-C₆ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C0₂R¹, CON(R³)₂, phenyl, 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, Ci-C₆ alkyl substituted by phenyl, Ci-C₆ alkyl substituted by 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, OR¹, Ci-C₆ alkylthio, N(R³)₂ or NR³COR², wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹, d-d alkyl, d-d haloalkyl, d-d alkylthio, d- C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl.

Preferably, Y² represents hydrogen, Ci-C₆ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C0₂R¹, CON(R³)₂, OR¹, d-C₆ alkylthio, N(R³)₂ or NR³COR², wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl and alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹, d-d alkyl, d-d haloalkyl, d-d alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl.

More preferably, Y² represents Ci-C₆ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C0₂R¹, CON(R³)₂, OR¹, d-C₆ alkylthio, N(R³)₂ or NR³COR², wherein the alkyl, cydoalkyi, cydoalkenyl, alkenyl, alkynyl are optionally substituted by one or more groups

independently selected from halogen, CN, OR¹ , C1-C4 alkyl and C1-C4 haloalkyl.

Even more preferablyY² represents Ci-C₆ alkyl, C₃-C₈ cydoalkyi, C₃-C₈ cydoalkenyl, C₂-C₆ alkenyl or C₂-C₆ alkynyl wherein the alkyl, cydoalkyi, cydoalkenyl, alkenyl and alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OR¹ , Ci-C₄ alkyl and d- C₄ haloalkyl.

Yet more preferably, Y² represents Ci-C₆ alkyl or C₃-C₈ cydoalkyi wherein the alkyl and cydoalkyi are optionally substituted by one or more groups independently selected from halogen, CN, OR¹ , C1-C4 alkyl and C_rC₄ haloalkyl.

Most preferably, Y² represents Ci-C₄ alkyl optionally substituted by one or more groups independently selected from halogen, C1-C2 alkyl, C1-C2 haloalkyl and C₃-C₆ cydoalkyi.

In another group of compounds, Y² represents C0₂R¹ , CON(R³)₂, OR¹ , Ci-C₆ alkylthio, N(R³)₂, NR³COR², wherein the alkyl, is optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹ , C_rC₄ alkyl, C_rC₄ haloalkyl, C_rC₄ alkylthio, C_rC₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl.

Preferably in this group of compounds, Y² represents C0₂R¹ , CON(R³)₂, OR¹ , Ci-C₆ alkylthio, N(R³)₂, NR³COR², wherein the alkyl, is optionally substituted by one or more groups independently selected from halogen, CN, OR¹ , Ci-C₄ alkyl, Ci-C₄ haloalkyl.

More preferably in this group of compounds, Y² represents C0₂R¹ , CON(R³)₂, N(R³)₂,

NR³COR².

Even more preferably in this group of compounds, Y² represents C0₂R¹.

Y³ represents hydrogen, Ci-C₆ alkyl, C₃-C₈ cydoalkyi, C₃-C₈ cydoalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, phenyl, naphthyl, 5- to 10- membered mono- or bicyclic heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, Ci-C₆ alkyl substituted by phenyl, Ci-C₆ alkyl substituted by 5- or 10- membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, C0₂R¹ , COR² or CON(R³)₂, wherein the alkyi , cydoalkyi, cydoalkenyl, alkenyl, alkynyl, phenyl, benzyl, naphthyl, and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², SH, N0₂, OR¹ , C_rC₄ alkyl, C C₄ haloalkyl, phenyl, halophenyl, C C₄ alkylphenyl, C₃-C₈ cydoalkyi, C₃-C₈ cydoalkenyl, Ci-C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl.

Preferably, Y³ represents hydrogen, Ci-C₆ alkyl, C₃-C₈ cydoalkyi, C₃-C₈ cydoalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, phenyl, 5- to 10-membered mono- or bicyclic heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, Ci-C₆ alkyl substituted by phenyl, Ci-C₆ alkyl substituted by 5- or 10- membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, C0₂R¹ , COR² or CON(R³)₂, wherein the alkyl, cydoalkyi, cydoalkenyl, alkenyl, alkynyl, phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², SH, N0₂, OR¹, C1-C4 alkyl, C1-C4 haloalkyl, phenyl, halophenyl, C1-C4 alkylphenyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl, C1-C4 alkylthio, C1-C4 alkylsulphinyl and C1-C4 alkylsulphonyl.

More prefereably, Y³ represents hydrogen, Ci-C₆ alkyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, phenyl, 5- to 10- membered mono- or bicyclic heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, d- C₆ alkyl substituted by phenyl, Ci-C₆ alkyl substituted by 5- or 10-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, C0₂R¹ or CON(R³)₂, wherein the alkyl, cycloalkyi, cycloalkenyl, alkenyl, alkynyl, phenyl and heterocycle are optionally substituted by one or more groups

independently selected from halogen, CN, OH, NH₂, NR³COR², SH, N0₂, OR¹, d-d alkyl, d-d haloalkyl, phenyl, halophenyl, C1-C4 alkylphenyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl, C1-C4 alkylthio, C1-C4 alkylsulphinyl and C1-C4 alkylsulphonyl.

Even more preferably, Y³ represents Ci-C₆ alkyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, phenyl, 5- to 10- membered mono- or bicyclic heterocycle containing one to three heteroatoms independently selected from O, S and N, , wherein the heterocycle can be aromatic, or fully or partially saturated, Ci-C₆ alkyl substituted by phenyl or Ci-C₆ alkyl substituted by 5- or 10-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, wherein the alkyl, cycloalkyi, cycloalkenyl, alkenyl, alkynyl, phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², SH, N0₂, OR¹, d-d alkyl, d-d haloalkyl, phenyl, halophenyl, d-d alkylphenyl, -d cycloalkyi, - cycloalkenyl, d-d alkylthio, d-d alkylsulphinyl and d-d alkylsulphonyl.

Y³ represents d- alkyl, - alkenyl or d-d-alkyl substituted by phenyl, wherein the alkyl, alkenyl, and phenyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹, d-C₄ alkyl, d-C₄ haloalkyl, phenyl, halophenyl, d-C₄ alkylphenyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl, d-C₄ alkylthio, d-C₄ alkylsulphinyl and d-C₄ alkylsulphonyl.

More preferably still, Y³ represents d-C₆ alkyl or C₂-C₆ alkenyl, wherein the alkyl and alkenyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹, phenyl, halophenyl, d-C₄ alkylphenyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl and d-C₄ alkylthio.

Most preferably, Y³ represents d-C₆ alkyl, C₂-C₆ alkenyl, benzyl, halobenzyl, d-C₄ alkylbenzyl, wherein the alkyl and alkenyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl and d-C₄ alkylthio.

In another group of compounds, Y³ represents d-C₆ alkyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, wherein the alkyl, alkenyl and alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², SH, N0₂, OR¹, d-C₄ alkyl, d-C₄ haloalkyl, phenyl, halophenyl, d-C₄ alkylphenyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl, d-C₄ alkylthio, d-C₄

alkylsulphinyl and d-C₄ alkylsulphonyl. More preferably in this group of compounds, Y³ represents C₂-C₆ alkenyl wherein the alkenyl is optionally substituted by one or more groups independently selected from halogen, CN, OH , NH₂, NR³COR², SH, N0₂, OR¹ , d-d alkyl, d-d haloalkyl, phenyl, halophenyl, d-d alkylphenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C1-C4 alkylthio, C1-C4 alkylsulphinyl and C1-C4 alkylsulphonyl.

Even more preferably in this group of compounds, Y³ represents C₂-C₆ alkenyl wherein the alkenyl is optionally substituted by one or more groups independently selected from halogen, CN, NR³COR², OR¹ , d-d alkyl, d-d haloalkyl, C₃-C₈ cycloalkyl, d-d alkylthio.

Yet in another group of compounds, Y³ represents C₀-C₆-alkyl-(phenyl), C₀-C₆-alkyl-(5- to 10- membered mono- or bicyclic heterocycle) containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, wherein the alkyl, phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², SH, N0₂, OR¹ , d-C₄ alkyl, d-C₄ haloalkyl, phenyl, halophenyl, Ci-C₄ alkylphenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, Ci-C₄

alkylsulphinyl and Ci-C₄ alkylsulphonyl.

More preferably in this group of compounds, Y³ represents Ci-C₂-alkyl-(phenyl) or Ci-C₂-alkyl-

(5- to 10- membered mono- or bicyclic heterocycle) containing one to three heteroatoms

independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, wherein the alkyl, phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², SH, N0₂, OR¹ , d-C₄ alkyl, d-C₄ haloalkyl, phenyl, halophenyl, Ci-C₄ alkylphenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, d-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl.

Even more preferably in this group of compounds, Y³ represents Ci-C₂-alkyl-(phenyl) or Ci-C₂- alkyl-(5- to 10- membered mono- or bicyclic heterocycle) containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, wherein the alkyl, phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, NR³COR², OR¹ , d-C₄ alkyl, d-C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl.

Y⁴ represents hydrogen, halogen, CN , d-C₆ alkyl, C₃-C₈ cycloalkyl, C₂-C₆ alkenyl, C₃-C₆ alkynyl, d-C₆ alkylthio, OR¹ , C0₂R¹ or CON(R³)₂, wherein the alkyl, cycloalkyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH , NH₂, NR³COR², OR¹ , d-d alkyl, d-C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d-C₄ alkylthio, d- C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl.

Preferably, Y⁴ represents hydrogen, halogen, CN , d-C₆ alkyl, d-C₆ alkylthio, OR¹ , C0₂R¹ or CON(R³)₂, wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹ , d-C₄ alkyl, d-C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl.

More preferably, hydrogen, halogen, CN , d-C₄ alkyl, d-C₄ alkylthio, OR¹ , C0₂R¹ or CON(R³)₂, wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, CN , OH , NH₂, NR³COR², OR¹ , C_rC₄ alkyl, C_rC₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C C₄ alkylthio, C1-C4 alkylsulphinyl and C1-C4 alkylsulphonyl.

Even more preferably, Y⁴ represents hydrogen, halogen, CN , C1-C2 alkyl, C1-C2 alkylthio or OR¹ , wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹ , C C₄ alkyl, C C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C1-C4 alkylthio, C1-C4 alkylsulphinyl and C1-C4 alkylsulphonyl.

Yet more preferably, Y⁴ represents hydrogen, halogen, CN, methyl, ethyl, methoxy or methylthio, wherein the methyl, ethyl, methoxy and methylthio are optionally substituted by one or more groups independently selected from halogen, CN and OR¹.

More preferably still, Y⁴ represents hydrogen, halogen or CN.Most preferably, Y⁴ represents hydrogen.

Y⁵ represents hydrogen, halogen, CN , Ci-C₆ alkyl, C₃-C₈ cycloalkyl, C₂-C₆ alkenyl, C₃-C₆ alkynyl, Ci-C₆ alkylthio, OR¹ , C0₂R¹ or CON(R³)₂, wherein the alkyl, cycloalkyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH , NH₂, NR³COR², OR¹ , C C₄ alkyl, C C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C C₄ alkylthio, C C₄ alkylsulphinyl and C1-C4 alkylsulphonyl.

Preferably, Y⁵ represents hydrogen, halogen, CN , C1-C4 alkyl, C1-C4 alkylthio, OR¹ , C0₂R¹ or CON(R³)₂, wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹ , C C₄ alkyl, C C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C1-C4 alkylthio, C1-C4 alkylsulphinyl and C1-C4 alkylsulphonyl.

More preferably, Y⁵ represents hydrogen, halogen, CN , C1-C4 alkyl, C1-C4 alkylthio, OR¹ , C0₂R¹ or CON(R³)₂, wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹ , C C₄ alkyl, C C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C1-C4 alkylthio, C1-C4 alkylsulphinyl and C1-C4 alkylsulphonyl.

Even more preferably, Y⁵ represents hydrogen, halogen, CN , Ci-C₂ alkyl, Ci-C₂ alkylthio or

OR¹ , wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹ , C C₄ alkyl, C C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C1-C4 alkylthio, C1-C4 alkylsulphinyl and C1-C4 alkylsulphonyl.

Yet more preferably, Y⁵ represents hydrogen, halogen, CN, methyl, ethyl, methoxy or methylthio, wherein the methyl, ethyl, methoxy and methylthio are optionally substituted by one or more groups independently selected from halogen, CN and OR¹.

More preferably still, Y⁵ represents hydrogen, halogen or CN.

Most preferably, Y⁵ represents hydrogen.

Each R is independently selected from hydrogen, Ci-C₈ alkyl, C₃-C₈ cycloalkyl, Ci-C₂ alkyl substituted by C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, phenyl, benzyl, a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R³), or Ci-C₂ alkyl substituted by a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R³), wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, C1-C4 alkyl, C1-C4 haloalkyl, d- C₄ alkoxy, C1-C4 haloalkoxy, Ci-C₄-alkoxy-Ci-C₄-alkyl and Ci-C₄ alkoxycarbonyl.

Preferably, each R is independently selected from hydrogen, Ci-C₈ alkyl, C₃-C₈ cycloalkyl, d- C₂ alkyl substituted by C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, phenyl, benzyl, a 5- or 6-membered heterocycle containing one to two heteroatoms independently selected from O, S and N, or Ci-C₂ alkyl substituted by a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, C C₄ alkyl, C_rC₄ haloalkyl, C C₄ alkoxy, Ci-C₄ haloalkoxy and Ci-C₄ alkoxycarbonyl.

More preferably, each R is independently selected from hydrogen, Ci-C₈ alkyl, C₃-C₆ cycloalkyl- Ci-C₂ alkyl, C₃-C₆ alkenyl, phenyl, benzyl, pyridyl or pyridyl-Ci-C₂ alkyl wherein the alkyl, cycloalkyl, alkenyl, phenyl, benzyl and pyridyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, C C₄ alkyl, C C₄ haloalkyl, C C₄ alkoxy, C C₄ haloalkoxy and Ci-C₄ alkoxycarbonyll.

Even more preferably, each R is independently selected from hydrogen, Ci-C₈ alkyl, C₃-C₆ alkenyl, phenyl, benzyl or pyridyl wherein the alkyl, cycloalkyl, alkenyl, phenyl and pyridyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, Ci-C₄ alkyl, Ci-C₄ haloalkyl, Ci-C₄ alkoxy and Ci-C₄ haloalkoxy.

Most preferably, each R is independently selected from hydrogen, Ci-C₈ alkyl or Ci-C₈ haloalkyl.

In another group of compounds, each R is independently selected from hydrogen, Ci-C₈ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, phenyl, benzyl or a 5- or 6- membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R³), wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, Ci-C₄ alkyl, Ci-C₄ haloalkyl, Ci-C₄ alkoxy, Ci-C₄ haloalkoxy and Ci-C₄-alkoxy-Ci-C₄-alkyl..

Preferably in this group of compounds, each R is independently selected from hydrogen, Ci-C₈ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, phenyl and benzyl, wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl and benzyl are optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, SH, Ci-C₄ alkyl, Ci-C₄- haloalkyl, Ci-C₄ alkoxy and Ci-C₄ haloalkoxy.

Even more preferably in this group of compounds, each R independently of one another represents hydrogen, Ci-C₈ alkyl, Ci-C₈ haloalkyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, C₃-C₈ haloalkenyl, C₃- C₈ haloalkynyl, Ci-C₄ alkylsulphonyl, Ci-C₄ haloalkylsulphonyl, phenyl or benzyl wherein the phenyl and benzyl are optionally substituted by one or more groups, e.g. one to five groups, independently selected from halogen, CN, NH₂, N0₂, OH, C C₄ alkyl, d-C₄-haloalkyl, C C₄ alkoxy and C C₄ haloalkoxy.

Yet more preferably in this group of compounds, each R independently of one another represents hydrogen, Ci-C₈ alkyl, Ci-C₈ haloalkyl, C₃-C₈ alkenyl, C₃-C₈ haloalkenyl, C₃-C₈ alkynyl, C₃- C₈ haloalkynyl, C1-C4 alkylsulphonyl, C1-C4 haloalkylsulphonyl, phenyl or benzyl wherein the phenyl and benzyl are optionally substituted by one or more groups, e.g. one to five groups, independently selected from halogen, CN, C1-C4 alkyl, Ci-C₄-haloalkyl, Ci-C₄ alkoxy and Ci-C₄ haloalkoxy.

It is particulary preferred in this group of compounds that each R independently of one another represents hydrogen, Ci-C₄ alkyl or Ci-C₄ haloalkyl.

In another group of compounds, each R is independently selected from the group of hydrogen, phenyl and a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R³), wherein the phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, SH, Ci-C₄ alkyl, C-|-C₄- haloalkyl, Ci-C₄ alkoxy, Ci-C₄ haloalkoxy and Ci-C₄-alkoxy-Ci-C₄-alkyl.

In a further group of compounds, each R independently of one another represents hydrogen, Ci-C₈ alkyl, Ci-C₈ haloalkyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, C₃-C₈ haloalkenyl, C₃-C₈ haloalkynyl, Ci-C₄ alkylsulphonyl, Ci-C₄ haloalkylsulphonyl, phenyl, benzyl or pyridyl, wherein the phenyl, benzyl and pyridyl are optionally substituted by one or more groups, e.g. one to five groups, independently selected from halogen, CN, NH₂, N0₂, OH, C_rC₄ alkyl, d-C₄-haloalkyl, C C₄ alkoxy and C C₄ haloalkoxy.

Yet more preferably in this group of compounds, each R independently of one another represents hydrogen, Ci-C₈ alkyl, Ci-C₈ haloalkyl, C₃-C₈ alkenyl, C₃-C₈ haloalkenyl, C₃-C₈ alkynyl, C₃- C₈ haloalkynyl, Ci-C₄ alkylsulphonyl, Ci-C₄ haloalkylsulphonyl, phenyl, benzyl, or pyridyl, wherein the phenyl, benzyl and pyridyl are optionally substituted by one or more groups, e.g. one to five groups, independently selected from halogen, CN, Ci-C₄ alkyl, Ci-C₄-haloalkyl, Ci-C₄ alkoxy and Ci-C₄ haloalkoxy.

Each R² is independently selected from hydrogen, Ci-C₆ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₈ alkenyl, C₂-C₈ alkynyl, phenyl, benzyl and pyridyl, wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and pyridyl groups are optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, Ci-C₄ alkyl, Ci-C₄ haloalkyl,

Ci-C₄ alkoxy, Ci-C₄ alkylthio and Ci-C₄ haloalkoxy.

Preferably, each R² is independently selected from the group of hydrogen, Ci-C₈ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₈ alkenyl, C₂-C₈ alkynyl and benzyl wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl and benzyl are optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, Ci-C₄ alkyl, Ci-C₄ haloalkyl, Ci-C₄ alkoxy and Ci-C₄ haloalkoxy.

More preferably, each R² independently of one another represents hydrogen, Ci-C₈ alkyl or d- C₈ haloalkyl.

Even more preferably, each R² independently of one another represents hydrogen, Ci-C₄ alkyl or Ci-C₄ haloalkyl.

Most preferably, R² represents methyl.

Each R³ is independently selected from hydrogen, Ci-C₆ alkyl, C₃-C₆ alkenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₆ alkynyl, phenyl, benzyl, CN, OR¹, COR², Ci-C₆ alkylsulphonyl and a 5- or 6- membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R ), wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN , NH₂, N0₂, OH, C1-C4 alkyl, Ci-C₄-haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy and Ci-C₄-alkoxy-Ci-C₄-alkyl;

and wherein when two radicals R³ are attached to the same nitrogen atom, these two radicals together with the nitrogen atom to which they are attached may form a heterocycle, wherein the heterocycle formed is optionally substituted by one or more groups independently selected from halogen, CN , NH₂, N0₂, OH, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy and C1-C4 haloalkoxy.

Preferably, each R³ is independently selected from the group of hydrogen, Ci-C₈ alkyl, C₂-C₈ alkenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₈ alkynyl, phenyl, benzyl, CN, OR¹ , COR² and Ci-C₈ alkylsulphonyl, wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl and benzyl are optionally substituted by one or more groups independently selected from halogen, CN , NH₂, N0₂, OH, C1-C4 alkyl, Ci-C₄-haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy and Ci-C₄-alkoxy-Ci-C₄-alkyl;

and wherein when two radicals R³ are attached to the same nitrogen atom, these two radicals together with the nitrogen atom to which they are attached may form a morpholine, piperidine, piperazine, imidazole, pyrazole or triazole;

wherein the cycle formed is optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, C_rC₄ alkyl, C_rC₄ haloalkyl, C C₄ alkoxy and C C₄ haloalkoxy.

Even more preferably, each R³ independently of one another represents hydrogen, Ci-C₈ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl or COR²; wherein when two radicals R³ are attached to the same nitrogen atom, these radicals can be identical or different; and wherein when two radicals R³ are attached to the same nitrogen atom, these two radicals together with the nitrogen atom to which they are attached may form a morpholine, piperidine, piperazine, imidazole, pyrazole or triazole; wherein the cycle formed is optionally substituted by one or more groups, e.g. one to five groups, independently selected from halogen, methyl, methoxy and halomethyl.

Yet more preferably, each R³ independently of one another represents hydrogen, C1-C4 alkyl, C₃-C₄ alkenyl, C₃-C₄ alkynyl or COR²; wherein when two radicals R³ are attached to the same nitrogen atom, these radicals can be identical or different; and wherein when two radicals R³ are attached to the same nitrogen atom, these two radicals together with the nitrogen atom to which they are attached may form a morpholine, piperidine, piperazine, imidazole, pyrazole or triazole, wherein the cycle formed is optionally substituted by one or more groups, e.g. one to five groups, independently selected from halogen, methyl, methoxy and halomethyl. More preferably still, each R³ independently of one another represents hydrogen, Ci-C₈ alkyi or

COR².

It is particularly preferred that each R³ independently of one another represents hydrogen or d- C₄ alkyi.

In another group of compounds, each R³ is selected from the group of hydrogen, phenyl and a

5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R⁸), wherein the phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, Ci-C₄ alkyi, Ci-C₄-haloalkyl, C1-C4 alkoxy, Ci-C₄ haloalkoxy and Ci-C₄-alkoxy-Ci-C₄-alkyl;

wherein when two radicals R³ are attached to the same nitrogen atom, these radicals can be identical or different.

Each R⁸ represents hydrogen, Ci-C₈ alkyi, Ci-C₈ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ , C₃-C₈ alkenyl, C₃-C₈ alkynyl or Ci-C₈ alkoxy-Ci-C₈ alkyi.

In one groupd of compounds according to formula (I), Y represents Ci-C₆ alkyi, C₂-C₆ alkenyl, C₃-C₆ alkynyl or OR¹ , wherein the alkyi, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, NR³COR², OR¹ , Ci-C₄ alkyi, Ci-C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y² represents hydrogen, Ci-C₆ alkyi, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C0₂R¹ , CON(R³)₂, OR¹ , C C₆ alkylthio, N(R³)₂ or NR³COR², wherein the alkyi, cycloalkyl, cycloalkenyl, alkenyl and alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH , NH₂, SH, N0₂, OR¹ , C C₄ alkyi, C C₄ haloalkyl, C C₄ alkylthio, C C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y³ represents hydrogen, Ci-C₆ alkyi, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, phenyl, 5- to 10-membered mono- or bicyclic heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, Ci-C₆ alkyi substituted by phenyl, Ci-C₆ alkyi substituted by 5- or 10-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, C0₂R¹ , COR² or CON(R³)₂, wherein the alkyi, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², SH, N0₂, OR¹ , C C₄ alkyi, Ci-C₄ haloalkyl, phenyl, halophenyl, Ci-C₄ alkylphenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d- C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y⁴ represents hydrogen, halogen, CN , C_rC₆ alkyi, C_rC₆ alkylthio, OR¹ , C0₂R¹ or CON(R³)₂, wherein the alkyi is optionally substituted by one or more groups independently selected from halogen, CN , OH , NH₂, NR³COR², OR¹ , C C₄ alkyi, C C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y⁵ represents hydrogen, halogen, CN , C C₄ alkyi, C C₄ alkylthio, OR¹ , C0₂R¹ or CON(R³)₂, wherein the alkyi is optionally substituted by one or more groups independently selected from halogen, CN , OH , NH₂, NR³COR², OR¹ , C C₄ alkyi, C C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl; each R is independently selected from hydrogen, Ci-C₆ alkyl, C₃-C₈ cycloalkyl, Ci-C₂ alkyl substituted by C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, phenyl, benzyl, a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R³), or Ci-C₂ alkyl substituted by a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R³), wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, Ci-C₄ alkyl, Ci-C₄ haloalkyl, Ci-C₄ alkoxy, C1-C4 haloalkoxy, Ci-C₄-alkoxy-Ci-C₄-alkyl and Ci-C₄ alkoxycarbonyl;

each R² is independently selected from the group of hydrogen, Ci-C₈ alkyl, C₃-C₈ cycloalkyl, C₃- C₈ cycloalkenyl, C₂-C₈ alkenyl, C₂-C₈ alkynyl and benzyl wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl and benzyl are optionally substituted by one or more groups independently selected from halogen, CN , NH₂, N0₂, OH, Ci-C₄ alkyl, Ci-C₄ haloalkyl, Ci-C₄ alkoxy and Ci-C₄ haloalkoxy; each R³ independently of one another represents hydrogen, Ci-C₈ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl or COR²; wherein when two radicals R³ are attached to the same nitrogen atom, these radicals can be identical or different; and wherein when two radicals R³ are attached to the same nitrogen atom, these two radicals together with the nitrogen atom to which they are attached may form a morpholine, piperidine, piperazine, imidazole, pyrazole or triazole; wherein the cycle formed is optionally substituted by one or more groups independently selected from halogen, methyl, methoxy and halomethyl.

In another group of compounds according to formula (I), Y represents Ci-C₆ alkyl, C₂-C₆ alkenyl, C₃-C₆ alkynyl or OR¹ , wherein the alkyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, Ci-C₄ alkyl, Ci-C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃- C₈ cycloalkenyl and Ci-C₄ alkylthio;

Y² represents Ci-C₆ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C0₂R , CON(R³)₂, OR , d-C₆ alkylthio, N(R³)₂ or NR³COR², wherein the alkyl, cycloalkyl,

cycloalkenyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OR¹ , Ci-C₄ alkyl and Ci-C₄ haloalkyl;

Y³ represents hydrogen, Ci-C₆ alkyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, phenyl, 5- to 10- membered mono- or bicyclic heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, Ci-C₆ alkyl substituted by phenyl, Ci-C₆ alkyl substituted by 5- or 10-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, C0₂R¹ or CON(R³)₂, wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH , NH₂, NR³COR², SH, N0₂, OR¹ , C C₄ alkyl, C C₄ haloalkyl, phenyl, halophenyl, Ci-C₄ alkylphenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, Ci-C₄

alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y⁴ represents hydrogen, halogen, CN , C C₄ alkyl, C C₄ alkylthio, OR¹ , C0₂R¹ or CON(R³)₂, wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, CN , OH , NH₂, NR³COR², OR¹ , C_rC₄ alkyi, C_rC₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C C₄ alkylthio, C1-C4 alkylsulphinyl and C1-C4 alkylsulphonyl;

Y⁵ represents hydrogen, halogen, CN , C C₄ alkyi, C C₄ alkylthio, OR¹ , C0₂R¹ or CON(R³)₂, wherein the alkyi is optionally substituted by one or more groups independently selected from halogen, CN , OH , NH₂, NR³COR², OR¹ , C C₄ alkyi, C C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

each R is independently selected from hydrogen, Ci-C₈ alkyi, C₃-C₈ cycloalkyl, Ci-C₂ alkyi substituted by C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, phenyl, benzyl, a 5- or 6-membered heterocycle containing one to two heteroatoms independently selected from O, S and N, or Ci-C₂ alkyi substituted by a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the alkyi, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH , NH₂, N0₂, SH, C C₄ alkyi, C C₄ haloalkyl, C C₄ alkoxy, C C₄ haloalkoxy and Ci-C₄ alkoxycarbonyl;

each R² independently of one another represents hydrogen, Ci-C₈ alkyi or Ci-C₈ haloalkyl; each R³ independently of one another represents hydrogen, Ci-C₄ alkyi, C₃-C₄ alkenyl, C₃-C₄ alkynyl or COR²; wherein when two radicals R³ are attached to the same nitrogen atom, these radicals can be identical or different; and wherein when two radicals R³ are attached to the same nitrogen atom, these two radicals together with the nitrogen atom to which they are attached may form a morpholine, piperidine, piperazine, imidazole, pyrazole or triazole, wherein the cycle formed is optionally substituted by one or more groups independently selected from halogen, methyl, methoxy and halomethyl.

In another group of compounds of formula (I), Y represents Ci-C₆ alkyi or OR¹ , wherein the alkyi is optionally substituted by one or more groups independently selected from halogen, Ci-C₄ alkyi, Ci-C₄ haloalkyl, C₃-C₈ cycloalkyl and C₃-C₈ cycloalkenyl;

Y² represents Ci-C₆ alkyi, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl or C₂-C₆ alkynyl wherein the alkyi, cycloalkyl, cycloalkenyl, alkenyl and alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OR¹ , Ci-C₄ alkyi and Ci-C₄ haloalkyl;

Y³ represents Ci-C₆ alkyi, C₂-C₆ alkenyl, C₂-C₆ alkynyl, phenyl, 5- to 10- membered mono- or bicyclic heterocycle containing one to three heteroatoms independently selected from O, S and N, , wherein the heterocycle can be aromatic, or fully or partially saturated, Ci-C₆ alkyi substituted by phenyl or Ci-C₆ alkyi substituted by 5- or 10-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, wherein the alkyi, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN , OH , NH₂, NR³COR², SH, N0₂, OR¹ , C C₄ alkyi, C C₄ haloalkyl, phenyl, halophenyl, C C₄ alkylphenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y⁴ represents hydrogen, halogen, CN , Ci-C₂ alkyi, Ci-C₂ alkylthio or OR¹ , wherein the alkyi is optionally substituted by one or more groups independently selected from halogen, CN , OH, NH₂, NR³COR², OR¹, C1-C4 alkyl, d-d haloalkyi, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d-d alkylthio, d- d alkylsulphinyl and C1-C4 alkylsulphonyl;

Y⁵ represents hydrogen, halogen, CN, C1-C2 alkyl, C1-C2 alkylthio or OR¹, wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹, C1-C4 alkyl, d-d haloalkyi, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d-d alkylthio, d- alkylsulphinyl and d-d alkylsulphonyl;

each R is independently selected from hydrogen, d-C₈ alkyl, -d cycloalkyl, d-d alkyl substituted by d-d cycloalkyl, d-d cycloalkenyl, d-d alkenyl, d-d alkynyl, phenyl, benzyl, a 5- or 6-membered heterocycle containing one to two heteroatoms independently selected from O, S and N, or d-d alkyl substituted by a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, d-C₄ alkyl, d-C₄ haloalkyi, d-C₄ alkoxy, d-C₄ haloalkoxy and d-C₄ alkoxycarbonyl;

each R² independently of one another represents hydrogen, d-C₄ alkyl or d-C₄ haloalkyi; each R³ independently of one another represents hydrogen, Ci-C₈ alkyl or COR².

In another group of compounds according to formula (I), Y represents d-C₄ alkyl optionally substituted by one or more groups independently selected from halogen, d-C₂ alkyl, Ci-C₂ haloalkyi and C₃-C₆ cycloalkyl;

Y² represents d-C₆ alkyl or C₃-C₈ cycloalkyl wherein the alkyl and cycloalkyl are optionally substituted by one or more groups independently selected from halogen, CN, OR¹, d-C₄ alkyl and d- C₄ haloalkyi;

Y³ represents d-C₆ alkyl, C₂-C₆ alkenyl or Ci-C₂-alkyl substituted by phenyl, wherein the alkyl, alkenyl, and phenyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹, d-C₄ alkyl, d-C₄ haloalkyi, phenyl, halophenyl, d-C₄ alkylphenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d-C₄ alkylthio, d-C₄ alkylsulphinyl and d-C₄ alkylsulphonyl;

Y⁴ represents hydrogen, halogen, CN, methyl, ethyl, methoxy or methylthio, wherein the methyl, ethyl, methoxy and methylthio are optionally substituted by one or more groups independently selected from halogen, CN and OR¹;

Y⁵ represents hydrogen, halogen, CN, methyl, ethyl, methoxy or methylthio, wherein the methyl, ethyl, methoxy and methylthio are optionally substituted by one or more groups independently selected from halogen, CN and OR¹;

each R is independently selected from hydrogen, Ci-C₈ alkyl, C₃-C₆ cycloalkyl-Ci-C₂ alkyl, C₃- C₆ alkenyl, phenyl, benzyl, pyridyl or pyridyl-Ci-C₂ alkyl wherein the alkyl, cycloalkyl, alkenyl, phenyl, benzyl and pyridyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, d-C₄ alkyl, d-C₄ haloalkyi, d-C₄ alkoxy, d-C₄ haloalkoxy and d- C₄ alkoxycarbonyl. In another group of compounds according to formula (I), Y² represents C1-C4 alkyi optionally substituted by one or more groups independently selected from halogen, Ci-C₂ alkyi, Ci-C₂ haloalkyl and C₃-C₆ cycloalkyi;

Y³ represents Ci-C₆ alkyi or C₂-C₆ alkenyl, wherein the alkyi and alkenyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹ , phenyl, halophenyl, Ci-C₄ alkylphenyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl and Ci-C₄ alkylthio;

Y⁴ represents hydrogen, halogen or CN;

Y⁵ represents hydrogen, halogen or CN;

each R is independently selected from hydrogen, Ci-C₈ alkyi, C₃-C₆ cycloalkyl-Ci-C₂ alkyi, C₃- C₆ alkenyl, phenyl, benzyl, pyridyl and pyridyl-Ci-C₂ alkyi wherein the alkyi, cycloalkyi, alkenyl, phenyl, benzyl and pyridyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, C_rC₄ alkyi, C_rC₄ haloalkyl, C C₄ alkoxy, C C₄ haloalkoxy and C C₄ alkoxycarbonyl.

In another group of compounds according to formula (I), Y³ represents Ci-C₆ alkyi, C₂-C₆ alkenyl, benzyl, halobenzyl, Ci-C₄ alkylbenzyl, wherein the alkyi and alkenyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹ , C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl and Ci-C₄ alkylthio;

Y⁴ represents hydrogen;

Y⁵ represents hydrogen;

each R is independently selected from hydrogen, Ci-C₈ alkyi, C₃-C₆ alkenyl, phenyl, benzyl or pyridyl wherein the alkyi, cycloalkyi, alkenyl, phenyl and pyridyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, Ci-C₄ alkyi, Ci-C₄ haloalkyl, Ci-C₄ alkoxy and Ci-C₄ haloalkoxy.

The compounds of formula (I) may exist as different geometric or optical isomers or in different tautomeric forms. These may be separated and isolated by well-known (usually chromatographic) techniques, and all such isomers and tautomers and mixtures thereof in all proportions as well as isotopic forms, such as deuterated compounds, are part of the present invention.

The compounds of the invention can be used in their free form or as a salt thereof. Acids that can be used for the preparation of salts are as follows: hydrofluoric, hydrochloric, hydrobromic, hydroiodic, sulfuric, phosphoric, nitric, acetic, trifluoroacetic, trichloroacetic, prioprionic, glycolic, thiocyanic, lactic, succinic, citric, benzoic, cinnamic, oxalic, formic, benzenesulfonic, p-toluenesulfonic, methanesulfonic, salicylic, p-aminosalicylic, 2-phenoxybenzoic, 2-acetoxybenzoic and 1 ,2- naphthalene-disulfonic acid

Intermediates that can be used to prepare compounds of formula (I) also form part of the present invention.

The compounds in Tables 1 to 5 illustrate compounds of formula (I).

Table X represents Table 1 (when X is 1 ), Table 2 (when X is 2), Table 3 (when X is 3), Table 4 (when X is 4), Table 5 (when X is 5). Table X

Table 1 : This table discloses compounds 1.001 to 1.448 of the formula (l-l), which is a compound of formula (I) wherein Y1 is methyl and Y², Y³, Y⁴ and Y⁵ have the specific meanings given in the Table X.

Table 2: This table discloses compounds 2.001 to 2.448 of the formula (l-ll), which is a compound of formula (I) wherein Y1 is ethyl and Y², Y³, Y⁴ and Y⁵ have the specific meanings given in the Table X

Table 3: This table discloses compounds 3.001 to 3.448 of the formula (l-lll), which is a compound of formula (I) wherein Y1 is n-propyl and Y², Y³, Y⁴ and Y⁵ have the specific meanings given in the Table X

Table 4: This table discloses compounds 4.001 to 4.448 of the formula (l-IV), which is a compound of formula (I) wherein Y1 is 2,2-difluoroethyl and Y², Y³, Y⁴ and Y⁵ have the specific meanings given in the Table X

Table 5: This table discloses compounds 5.001 to 5.448 of the formula (l-V), which is a compound of formula (I) wherein Y1 is 2,2,2-trifluoroethyl and Y², Y³, Y⁴ and Y⁵ have the specific meanings given in the Table X

Compounds of Tables 1 to 5 can be prepared according to the following methods.

Scheme 1

The compounds of formula (I) can be obtained by transformation of a compound of formula (II), wherein Y , Y², Y⁴ and Y⁵ are as defined for formula (I), with a hydroxylamine or hydroxylammonium halide of formula (VII), wherein Y³ is as defined for a compound of formula (I), with or without the presence of base, such as sodium acetate, sodium bicarbonate or potassium carbonate, or an acid, such as para-toluenesulfonic acid or trifluoroacetic acid.

Scheme 2

(I") (")

The compounds of formula (II) can be obtained by transformation of a compound of formula (III), wherein Y , Y⁴ and Y⁵ are as defined for formula (I), with a stannane, such as 1- methoxyvinyl(tributyl)stannane or [2,2-difluoro-1-(2-methoxyethoxymethoxy)vinyl]-trimethyl-stannane, and a catalyst, such as tetrakis(triphenylphosphine) palladium, bis(triphenylphosphine) palladium dichloride. Scheme 3

Alternatively, the compound of formula (II) can be obtained by transformation of a compound of formula (III), wherein Y , Y⁴ and Y⁵ are as defined for formula (I), with a radical trap of formula (IV), wherein Y² and Y³ are as defined for formula (I), and using a radical initiator such as 2,2'- azobisisobutyronitrile or 1 , 1 '-azobis(cyclohexanecarbonitrile).

Scheme 4

The compounds of formula (III) can be obtained by transformation of a compound of formula (V), wherein Y , Y⁴ and Y⁵ are as defined for formula I, with a nitrite, such isomyl nitrite, or a mixture of sodium nitrite and an acid, such as hydrogen chloride; followed by basification to pH 12 and addition of hydroxylamine.

Scheme 5

(VI) (V)

The compounds of formula (V) can be obtained by transformation of a compound of formula

(VI), wherein Y , Y⁴ and Y⁵ are as defined for formula (I), with ethyl 2-cyanoacetate.

The compounds of formula (VI) are known or can be made by known methods from known products.

Certain intermediates described in the above schemes are novel and as such form a further aspect of the invention. Compounds according to the invention may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against phytopathogenic

microorganisms (such as fungi, bacteria or viruses, in particular against diseases that are caused by fungi) or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile, improved physico-chemical properties, or increased biodegradability).

The invention therefore also relates to a method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms, especially fungi, wherein a compound of formula (I) is applied as active ingredient to the plants, to parts thereof or the locus thereof.

The term "plants" refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage, and fruits.

The term "locus" as used herein means fields in or on which plants are growing, or where seeds of cultivated plants are sown, or where seed will be placed into the soil. It includes soil, seeds, and seedlings, as well as established vegetation.

The compounds of formula I can be used in the agricultural sector and related fields of use e.g. as active ingredients for controlling plant pests or on non-living materials for control of spoilage microorganisms or organisms potentially harmful to man.

The compounds of formula (I) according to the invention are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and are used for protecting numerous useful plants. The compounds of formula (I) can be used to inhibit or destroy the diseases that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later from

phytopathogenic microorganisms.

It is possible to use compounds of formula I as fungicide. The term "fungicide" as used herein means a compound that controls, modifies, or prevents the growth of fungi. The term "fungicidally effective amount" means the quantity of such a compound or combination of such compounds that is capable of producing an effect on the growth of fungi. Controlling or modifying effects include all deviation from natural development, such as killing, retardation and the like, and prevention includes barrier or other defensive formation in or on a plant to prevent fungal infection.

A preferred method of applying a compound of formula (I) is foliar application. The frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen. However, the compounds of formula (I) may also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field.

It is also possible to use compounds of formula (I) as dressing agents for the treatment of plant propagation material, in particular of seeds and plant cuttings (e.g. rice), for the protection against fungal infections as well as against phytopathogenic fungi occurring in the soil. The propagation material can be treated with a composition comprising a compound of formula I before planting: seed, for example, can be dressed before being sown. The active ingredients according to the invention can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation. The composition can also be applied to the planting site when the propagation material is being planted, for example, to the seed furrow during sowing. The invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated.

The term "plant propagation material" denotes all generative parts of a plant, for example seeds or vegetative parts of plants such as cuttings and tubers. It includes seeds in the strict sense, as well as roots, fruits, tubers, bulbs, rhizomes, and parts of plants. Preferably "plant propagation material" is understood to denote seeds.

Furthermore the compounds of formula (I) according to the invention may be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage or in hygiene management.

In addition, the invention could be used to protect non-living materials from fungal attack, e.g. lumber, wall boards and paint.

The compounds of formula (I) are particularly effective to protect useful plants or plant propagation material thereof against phytopathogenic fungi belonging to the following classes:

Absidia corymbifera, Alternaria spp, Aphanomyces spp, Ascochyta spp, Aspergillus spp.

including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terms, Aureobasidium spp. including A. pullulans, Blastomyces dermatitidis, Blumeria graminis, Bremia lactucae, Botryosphaeria spp.

including B. dothidea, B. obtusa, Botrytis spp. inclusing B. cinerea, Candida spp. including C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. tropicalis, Cephaloascus fragrans, Ceratocystis spp, Cercospora spp. including C. arachidicola, Cercosporidium personatum, Cladosporium spp, Claviceps purpurea, Coccidioides immitis, Cochliobolus spp, Colletotrichum spp. including C. musae, Cryptococcus neoformans, Diaporthe spp, Didymella spp, Drechslera spp, Elsinoe spp,

Epidermophyton spp, Erwinia amylovora, Erysiphe spp. including E. cichoracearum, Eutypa lata, Fusarium spp. including F. culmorum, F. graminearum, F. langsethiae, F. moniliforme, F. oxysporum, F. proliferatum, F. subglutinans, F. solani, Gaeumannomyces graminis, Gibberella fujikuroi, Gloeodes pomigena, Gloeosporium musarum, Glomerella cingulate, Guignardia bidwellii, Gymnosporangium juniperi-virginianae, Helminthosporium spp, Hemileia spp, Histoplasma spp. including H. capsulatum, Laetisaria fuciformis, Leptographium lindbergi, Leveillula taurica, Lophodermium seditiosum,

Microdochium nivale, Microsporum spp, Monilinia spp, Mucor spp, Mycosphaerella spp. including M. graminicola, M. pomi, Oncobasidium theobromaeon, Ophiostoma piceae, Paracoccidioides spp, Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp, Peronosclerospora spp. Including P. maydis, P. philippinensis and P. sorghi, Peronospora spp, Phaeosphaeria nodorum, Phakopsora pachyrhizi, Phellinus igniarus, Phialophora spp, Phoma spp, Phomopsis viticola, Phytophthora spp. including P. infestans, Plasmopara spp. including P. halstedii, P. viticola, Pleospora spp.,

Podosphaera spp. including P. leucotricha, Polymyxa graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp, Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopeziza tracheiphila, Puccinia Spp. including P. hordei, P. recondita, P. striiformis, P. triticina, Pyrenopeziza spp, Pyrenophora spp, Pyricularia spp. including P. oryzae, Pythium spp. including P. ultimum, Ramularia spp, Rhizoctonia spp, Rhizomucor pusillus, Rhizopus arrhizus, Rhynchosporium spp, Scedosporium spp. including S. apiospermum and S. prolificans, Schizothyrium pomi, Sclerotinia spp, Sclerotium spp, Septoria spp, including S. nodorum, S. tritici, Sphaerotheca macularis,

Sphaerotheca fusca (Sphaerotheca fuliginea), Sporothorix spp, Stagonospora nodorum, Stemphylium spp,. Stereum hirsutum, Thanatephorus cucumeris, Thielaviopsis basicola, Tilletia spp, Trichoderma spp. including T. harzianum, T. pseudokoningii, T. viride, Trichophyton spp, Typhula spp, Uncinula necator, Urocystis spp, Ustilago spp, Venturia spp. including V. inaequalis, Verticillium spp, and Xanthomonas spp, in particular Ascomycetes (e.g. the genus Cochliobolus, Colletotrichum, Fusarium, Gaeumannomyces, Giberella, Monographella, Microdochium, Penicillium, Phoma, Pyricularia, Magnaporthe, Septoria, Pseudocercosporella, Tapesia and Thielaviopsis); Basidiomycetes (e.g. the genus Phakopsora, Puccinia, Rhizoctonia, Thanatephorus, Sphacelotheca, Tilletia, Typhula and Ustilago); Fungi imperfecti (also known as Deuteromycetes; e.g. the genus Ascochyta, Diplodia, Erysiphe, Fusarium, Helminthosporium, Phomopsis, Pyrenophora and Verticillium); Oomycetes (e.g. Aphanomyces, Peronospora, Peronosclerospora, Phytophthora, Plasmopara, Pseudoperonospora, Pythium); and Zygomycets (e.g. the genus Rhizopus).

Crops of useful plants in which the composition according to the invention can be used include perennial and annual crops, such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries; cereals for example barley, maize (corn), millet, oats, rice, rye, sorghum triticale and wheat; fibre plants for example cotton, flax, hemp, jute and sisal; field crops for example sugar and fodder beet, coffee, hops, mustard, oilseed rape (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees for example apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear and plum; grasses for example Bermuda grass, bluegrass, bentgrass, centipede grass, fescue, ryegrass, St. Augustine grass and Zoysia grass; herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes for example beans, lentils, peas and soya beans; nuts for example almond, cashew, ground nut, hazelnut, peanut, pecan, pistachio and walnut; palms for example oil palm; ornamentals for example flowers, shrubs and trees; other trees, for example cacao, coconut, olive and rubber; vegetables for example asparagus, aubergine, broccoli, cabbage, carrot, cucumber, garlic, lettuce, marrow, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and vines for example grapes.

Crops are to be understood as being those which are naturally occurring, obtained by conventional methods of breeding, or obtained by genetic engineering. They include crops which contain so-called output traits (e.g. improved storage stability, higher nutritional value and improved flavour).

Crops are to be understood as also including those crops which have been rendered tolerant to herbicides like bromoxynil or classes of herbicides such as ALS-, EPSPS-, GS-, HPPD- and PPO- inhibitors. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding is Clearfield® summer canola. Examples of crops that have been rendered tolerant to herbicides by genetic engineering methods include e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady®, Herculex I® and LibertyLink®.

Crops are also to be understood as being those which naturally are or have been rendered resistant to harmful insects. This includes plants transformed by the use of recombinant DNA techniques, for example, to be capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria. Examples of toxins which can be expressed include δ-endotoxins, vegetative insecticidal proteins (Vip), insecticidal proteins of bacteria colonising nematodes, and toxins produced by scorpions, arachnids, wasps and fungi.

An example of a crop that has been modified to express the Bacillus thuringiensis toxin is the Bt maize KnockOut® (Syngenta Seeds). An example of a crop comprising more than one gene that codes for insecticidal resistance and thus expresses more than one toxin is VipCot® (Syngenta Seeds). Crops or seed material thereof can also be resistant to multiple types of pests (so-called stacked transgenic events when created by genetic modification). For example, a plant can have the ability to express an insecticidal protein while at the same time being herbicide tolerant, for example Herculex I® (Dow AgroSciences, Pioneer Hi-Bred International).

The compounds of formula (I) can be used in unmodified form or, preferably, together with carriers and adjuvants conventionally employed in the art of formulation.

Therefore the invention also relates to compositions for controlling and protecting against phytopathogenic microorganisms, comprising a compound of formula (I) and an inert carrier, and to a method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms, wherein a composition, comprising a compound of formula (I) as active ingredient and an inert carrier, is applied to the plants, to parts thereof or the locus thereof.

To this end compounds of formula (I) and inert carriers are conveniently formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances. As with the type of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances. The compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects.

Suitable carriers and adjuvants (auxiliaries) can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers. Such carriers are for example described in WO 97/33890.

A formulation, i.e. a composition comprising the compound of formula (I) and, if desired, a solid or liquid adjuvant, is prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface-active compounds (surfactants).

The compounds of formula I may be used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they may be conveniently formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances. As with the type of the

compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances. The compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects.

Suitable carriers and adjuvants, e.g. for agricultural use, can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers. Such carriers are for example described in WO 97/33890.

Suspension concentrates are aqueous formulations in which finely divided solid particles of the active compound are suspended. Such formulations include anti-settling agents and dispersing agents and may further include a wetting agent to enhance activity as well an anti-foam and a crystal growth inhibitor. In use, these concentrates are diluted in water and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate.

Wettable powders are in the form of finely divided particles which disperse readily in water or other liquid carriers. The particles contain the active ingredient retained in a solid matrix. Typical solid matrices include fuller's earth, kaolin clays, silicas and other readily wet organic or inorganic solids. Wettable powders normally contain from 5% to 95% of the active ingredient plus a small amount of wetting, dispersing or emulsifying agent.

Emulsifiable concentrates are homogeneous liquid compositions dispersible in water or other liquid and may consist entirely of the active compound with a liquid or solid emulsifying agent, or may also contain a liquid carrier, such as xylene, heavy aromatic naphthas, isophorone and other nonvolatile organic solvents. In use, these concentrates are dispersed in water or other liquid and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate.

Granular formulations include both extrudates and relatively coarse particles and are usually applied without dilution to the area in which treatment is required. Typical carriers for granular formulations include sand, fuller's earth, attapulgite clay, bentonite clays, montmorillonite clay, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, kaolin, dolomite, plaster, wood flour, ground corn cobs, ground peanut hulls, sugars, sodium chloride, sodium sulphate, sodium silicate, sodium borate, magnesia, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulphate and other organic or inorganic materials which absorb or which can be coated with the active compound. Granular formulations normally contain 5% to 25% of active ingredients which may include surface-active agents such as heavy aromatic naphthas, kerosene and other petroleum fractions, or vegetable oils; and/or stickers such as dextrins, glue or synthetic resins. Dusts are free-flowing admixtures of the active ingredient with finely divided solids such as talc, clays, flours and other organic and inorganic solids which act as dispersants and carriers.

Microcapsules are typically droplets or granules of the active ingredient enclosed in an inert porous shell which allows escape of the enclosed material to the surroundings at controlled rates. Encapsulated droplets are typically 1 to 50 microns in diameter. The enclosed liquid typically constitutes 50 to 95% of the weight of the capsule and may include solvent in addition to the active compound. Encapsulated granules are generally porous granules with porous membranes sealing the granule pore openings, retaining the active species in liquid form inside the granule pores. Granules typically range from 1 millimetre to 1 centimetre and preferably 1 to 2 millimetres in diameter.

Granules are formed by extrusion, agglomeration or prilling, or are naturally occurring. Examples of such materials are vermiculite, sintered clay, kaolin, attapulgite clay, sawdust and granular carbon. Shell or membrane materials include natural and synthetic rubbers, cellulosic materials, styrene- butadiene copolymers, polyacrylonitriles, polyacrylates, polyesters, polyamides, polyureas, polyurethanes and starch xanthates.

Other useful formulations for agrochemical applications include simple solutions of the active ingredient in a solvent in which it is completely soluble at the desired concentration, such as acetone, alkylated naphthalenes, xylene and other organic solvents. Pressurised sprayers, wherein the active ingredient is dispersed in finely-divided form as a result of vaporisation of a low boiling dispersant solvent carrier, may also be used.

Suitable agricultural adjuvants and carriers that are useful in formulating the compositions of the invention in the formulation types described above are well known to those skilled in the art.

Liquid carriers that can be employed include, for example, water, toluene, xylene, petroleum naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetonalcohol, 1 ,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, Ν,Ν-dimethyl formamide, dimethyl sulfoxide, 1 ,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkyl pyrrolidinone, ethyl acetate, 2-ethyl hexanol, ethylene carbonate, 1 ,1 , 1-trichloroethane, 2-heptanone, alpha pinene, d-limonene, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol diacetate, glycerol monoacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropyl benzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxy-propanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octyl amine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol (PEG400), propionic acid, propylene glycol, propylene glycol monomethyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylene sulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, methanol, ethanol, isopropanol, and higher molecular weight alcohols such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, etc., ethylene glycol, propylene glycol, glycerine and N-methyl-2-pyrrolidinone. Water is generally the carrier of choice for the dilution of concentrates.

Suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, chalk, diatomaxeous earth, lime, calcium carbonate, bentonite clay, fuller's earth, cotton seed hulls, wheat flour, soybean flour, pumice, wood flour, walnut shell flour and lignin.

A broad range of surface-active agents are advantageously employed in both said liquid and solid compositions, especially those designed to be diluted with carrier before application. These agents, when used, normally comprise from 0.1 % to 15% by weight of the formulation. They can be anionic, cationic, non-ionic or polymeric in character and can be employed as emulsifying agents, wetting agents, suspending agents or for other purposes. Typical surface active agents include salts of alkyl sulfates, such as diethanolammonium lauryl sulphate; alkylarylsulfonate salts, such as calcium dodecylbenzenesulfonate; alkylphenol-alkylene oxide addition products, such as nonylphenol-C.sub. 18 ethoxylate; alcohol-alkylene oxide addition products, such as tridecyl alcohol-C.sub. 16 ethoxylate; soaps, such as sodium stearate; alkylnaphthalenesulfonate salts, such as sodium

dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2-ethylhexyl) sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryl

trimethylammonium chloride; polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono and dialkyl phosphate esters.

Other adjuvants commonly utilized in agricultural compositions include crystallisation inhibitors, viscosity modifiers, suspending agents, spray droplet modifiers, pigments, antioxidants, foaming agents, anti-foaming agents, light-blocking agents, compatibilizing agents, antifoam agents, sequestering agents, neutralising agents and buffers, corrosion inhibitors, dyes, odorants, spreading agents, penetration aids, micronutrients, emollients, lubricants and sticking agents.

In addition, further, other biocidally active ingredients or compositions may be combined with the compositions of the invention and used in the methods of the invention and applied simultaneously or sequentially with the compositions of the invention. When applied simultaneously, these further active ingredients may be formulated together with the compositions of the invention or mixed in, for example, the spray tank. These further biocidally active ingredients may be fungicides, herbicides, insecticides, bactericides, acaricides, nematicides and/or plant growth regulators.

In addition, the compositions of the invention may also be applied with one or more systemically acquired resistance inducers ("SAR" inducer). SAR inducers are known and described in, for example, United States Patent No. US 6,919,298 and include, for example, salicylates and the commercial SAR inducer acibenzolar-S-methyl.

The agrochemical formulations will usually contain from 0.1 to 99% by weight, preferably from

0.1 to 95% by weight, of the compound of formula (I), 99.9 to 1 % by weight, preferably 99.8 to 5% by weight, of a solid or liquid adjuvant, and from 0 to 25% by weight, preferably from 0.1 to 25% by weight, of a surfactant.

Whereas it is preferred to formulate commercial products as concentrates, the end user will normally use dilute formulations. Advantageous rates of application are normally from 5g to 2kg of active ingredient (a.i.) per hectare (ha), preferably from 10g to 1 kg a.i./ha, most preferably from 20g to 600g a.i./ha. When used as seed drenching agent, convenient rates of application are from 10mg to 1g of active substance per kg of seeds. The rate of application for the desired action can be determined by experiments. It depends for example on the type of action, the developmental stage of the useful plant, and on the application (location, timing, application method) and can, owing to these parameters, vary within wide limits.

Normally, in the management of a crop a grower would use one or more other agronomic chemicals in addition to the compound of the present invention. Examples of agronomic chemicals include pesticides, such as acaricides, bactericides, fungicides, herbicides, insecticides, nematicides, as well as plant nutrients and plant fertilizers.

Accordingly, the present invention provides a composition comprising a compound of formula (I) according to the present invention together with one or more pesticides, plant nutrients or plant fertilizers. The combination may also encompass specific plant traits incorporated into the plant using any means, for example conventional breeding or genetic modification. Such compositions may also contain one or more inert carriers as described above.

The invention also provides for the use of provides a composition comprising a compound of formula (I) according to the present invention together with one or more pesticides, plant nutrients or plant fertilizers. The combination may also encompass specific plant traits incorporated into the plant using any means, for example conventional breeding or genetic modification.

Suitable examples of plant nutrients or plant fertilizers are calcium sulfate (CaS0₄), calcium nitrate (Ca(N0₃)2.4H₂0), calcium carbonate (CaC0₃), potassium nitrate (KN0₃), magnesium sulfate (MgS0₄), potassium hydrogen phosphate (KH₂P0₄), manganese sulfate (MnS0₄), copper sulfate (CuS0₄), zinc sulfate (ZnS0₄), nickel chloride (NiCI₂), cobalt sulfate (CoS0₄), potassium hydroxide (KOH), sodium chloride (NaCI), boric acid (H₃B0₃) and metal salts thereof (Na₂Mo0₄). The nutrients may be present in an amount of 5% to 50% by weight, preferably of 10% to 25% by weight or of 15% to 20% by weight each. Preferred additional nutrients are urea ((NH₂)₂CO), melamine (C₃H₆N₆), potassium oxide (K₂0), and inorganic nitrates. The most preferred additional plant nutrient is potassium oxide. Where the preferred additional nutrient is urea, it is present in an amount of generally 1 % to 20% by weight, preferably 2% to 10% by weight or of 3% to 7% by weight.

Suitable examples of pesticides are acycloamino acid fungicides, aliphatic nitrogen fungicides, amide fungicides, anilide fungicides, antibiotic fungicides, aromatic fungicides, arsenical fungicides, aryl phenyl ketone fungicides, benzamide fungicides, benzanilide fungicides, benzimidazole fungicides, benzothiazole fungicides, botanical fungicides, bridged diphenyl fungicides, carbamate fungicides, carbanilate fungicides, conazole fungicides, copper fungicides, dicarboximide fungicides, , dinitrophenol fungicides, dithiocarbamate fungicides, dithiolane fungicides, furamide fungicides, furanilide fungicides, hydrazide fungicides, imidazole fungicides, mercury fungicides, morpholine fungicides, organophosphorous fungicides, organotin fungicides, oxathiin fungicides, oxazole fungicides, phenylsulfamide fungicides, polysulfide fungicides, pyrazole fungicides, pyridine fungicides, pyrimidine fungicides, pyrrole fungicides, quaternary ammonium fungicides, quinoline fungicides, quinone fungicides, quinoxaline fungicides, strobilurin fungicides, sulfonanilide fungicides, thiadiazole fungicides, thiazole fungicides, thiazolidine fungicides, thiocarbamate fungicides, thiophene fungicides, triazine fungicides, triazole fungicides, triazolopyrimidine fungicides, urea fungicides, valinamide fungicides, zinc fungicides, Benzoylureas, carbamates, chloronicotinyis, diacylhydrazines. diamides, fiproies, macroiides, nitroimines, nitromethylenes, organochlorines, organophosphates, organosilicons, organotins, phenyipyrazoles, phosphoric esters, pyrethroids, spinosyns, tetramic acid derivatives, tetronic acid derivatives, Antibiotic nematicides, avermectin nematicides, botanical nematicides, carbamate nematicides, oxime carbamate nematicides, organophosphorus nematicides, nematophagous fungi or bacteria, amide herbicides, anilide herbicides, arsenical herbicides, arylalanine herbicides, aryloxyphenoxypropionic herbicides, benzofuranyl herbicides, benzoic acid herbicides, benzothiazole herbicides, benzoylcyclohexanedione herbicides, carbamate herbicides, carbanilate herbicides, chloroacetanilide herbicides, chlorotriazine herbicides, cyclohexene oxmie herbicides, cyclopropylisoxazole herbicides, dicarboximide herbicides, dinitroaniline herbicides, dinitrophenol herbicides, diphenyl ether herbicides, dithiocarbamate herbicides, fluoroalkyltriazine herbicides, halogenated aliphatic herbicides, imidazolinone herbicides, inorganic herbicides, methoxytriazine herbicides, methylthiotriazine herbicides, nitrile herbicides, nitrophenyl ether herbicides, organophosphorous herbicides, oxadiazolone herbicides, oxazole herbicides, phenoxy herbicides, phenoxyacetic herbicides, phenoxybutyric herbicides, phenoxypropionic herbicides, phenylenediamine herbicides, phenylurea herbicides, phthalic acid herbicides, picolinic acid herbicides, pyrazole herbicides, pyridazine herbicides, pyridazinone herbicides, pyridine herbicides, pyrimidinediamine herbicides, pyrimidinyloxybenzylamine herbicides, pyrimidinylsulfonylurea herbicides, quaternary ammonium herbicides, quinolinecarboxylic acid herbicides, sulfonamide herbicides, sulfonanilide herbicides, sulfonylurea herbicides, thiadiazolylurea herbicides, thioamide herbicides, thiocarbamate herbicides, thiocarbonate herbicides, thiourea herbicides, triazine herbicides,triazinone herbicides, triazinylsulfonylurea herbicides, triazole herbicides, triazolone herbicides, triazolopyrimidine herbicides, uracil herbicides, urea herbicides, microbials, plant extracts, pheromones, macrobials and other biologicals.

The following mixtures of the compounds of formula I with active ingredients are preferred (the abbreviation "TX" means "one compound selected from the group consisting of the compounds described in Tables 1 to 5 (above) or Table 6 (below) of the present invention"):

an adjuvant selected from the group of substances consisting of petroleum oils (alternative name) (628) + TX,

an acaricide selected from the group of substances consisting of 1 ,1-bis(4-chlorophenyl)-2- ethoxyethanol (lUPAC name) (910) + TX, 2,4-dichlorophenyl benzenesulfonate (lUPAC/Chemical Abstracts name) (1059) + TX, 2-fluoro-A/-methyl-A/-1-naphthylacetamide (lUPAC name) (1295) + TX, 4-chlorophenyl phenyl sulfone (lUPAC name) (981 ) + TX, abamectin (1 ) + TX, acequinocyl (3) + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, alpha- cypermethrin (202) + TX, amidithion (870) + TX, amidoflumet [CCN] + TX, amidothioate (872) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, aramite (881 ) + TX, arsenous oxide (882) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azobenzene (lUPAC name) (888) + TX, azocyclotin (46) + TX, azothoate (889) + TX, benomyl (62) + TX, benoxafos (alternative name) [CCN] + TX, benzoximate (71 ) + TX, benzyl benzoate (lUPAC name) [CCN] + TX, bifenazate (74) + TX, bifenthrin (76) + TX, binapacryl (907) + TX, brofenvalerate (alternative name) + TX, bromocyclen (918) + TX, bromophos (920) + TX, bromophos-ethyl (921 ) + TX, bromopropylate (94) + TX, buprofezin (99) + TX, butocarboxim (103) + TX, butoxycarboxim (104) + TX, butylpyridaben (alternative name) + TX, calcium polysulfide (lUPAC name) (1 1 1 ) + TX, camphechlor (941 ) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbophenothion (947) + TX, CGA 50'439 (development code) (125) + TX, chinomethionat (126) + TX, chlorbenside (959) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorfenapyr (130) + TX, chlorfenethol (968) + TX, chlorfenson (970) + TX, chlorfensulfide (971 ) + TX, chlorfenvinphos (131 ) + TX, chlorobenzilate (975) + TX, chloromebuform (977) + TX, chloromethiuron (978) + TX, chloropropylate (983) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, clofentezine (158) + TX, closantel (alternative name) [CCN] + TX, coumaphos (174) + TX, crotamiton (alternative name) [CCN] + TX, crotoxyphos (1010) + TX, cufraneb (1013) + TX, cyanthoate (1020) + TX, cyflumetofen (CAS Reg. No.: 400882-07-7) + TX, cyhalothrin (196) + TX, cyhexatin (199) + TX, cypermethrin (201 ) + TX, DCPM (1032) + TX, DDT (219) + TX, demephion (1037) + TX, demephion-0 (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-0 (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton-S-methylsulfon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diazinon (227) + TX, dichlofluanid (230) + TX, dichlorvos (236) + TX, dicliphos (alternative name) + TX, dicofol (242) + TX, dicrotophos (243) + TX, dienochlor (1071 ) + TX, dimefox (1081 ) + TX, dimethoate (262) + TX, dinactin (alternative name) (653) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinobuton (269) + TX, dinocap (270) + TX, dinocap-4 [CCN] + TX, dinocap-6 [CCN] + TX, dinocton (1090) + TX, dinopenton (1092) + TX, dinosulfon (1097) + TX, dinoterbon (1098) + TX, dioxathion (1 102) + TX, diphenyl sulfone (lUPAC name) (1 103) + TX, disulfiram (alternative name) [CCN] + TX, disulfoton (278) + TX, DNOC (282) + TX, dofenapyn (1 1 13) + TX, doramectin (alternative name) [CCN] + TX, endosulfan (294) + TX, endothion (1 121 ) + TX, EPN (297) + TX, eprinomectin (alternative name) [CCN] + TX, ethion (309) + TX, ethoate-methyl (1 134) + TX, etoxazole (320) + TX, etrimfos (1 142) + TX, fenazaflor (1 147) + TX, fenazaquin (328) + TX, fenbutatin oxide (330) + TX, fenothiocarb (337) + TX, fenpropathrin (342) + TX, fenpyrad (alternative name) + TX, fenpyroximate (345) + TX, fenson (1 157) + TX, fentrifanil (1 161 ) + TX, fenvalerate (349) + TX, fipronil (354) + TX, fluacrypyrim (360) + TX, fluazuron (1 166) + TX, flubenzimine (1 167) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenoxuron (370) + TX, flumethrin (372) + TX, fluorbenside (1 174) + TX, fluvalinate (1 184) + TX, FMC 1 137 (development code) (1 185) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, gamma-HCH (430) + TX, glyodin (1205) + TX, halfenprox (424) + TX, heptenophos (432) + TX, hexadecyl cyclopropanecarboxylate (lUPAC/Chemical Abstracts name) (1216) + TX, hexythiazox (441 ) + TX, iodomethane (lUPAC name) (542) + TX, isocarbophos (alternative name) (473) + TX, isopropyl 0-(methoxyaminothiophosphoryl)salicylate (lUPAC name) (473) + TX, ivermectin (alternative name) [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, lindane (430) + TX, lufenuron (490) + TX, malathion (492) + TX, malonoben (1254) + TX, mecarbam (502) + TX, mephosfolan (1261 ) + TX, mesulfen (alternative name) [CCN] + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methidathion (529) + TX, methiocarb (530) + TX, methomyl (531 ) + TX, methyl bromide (537) + TX, metolcarb (550) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime (alternative name) [CCN] + TX, mipafox (1293) + TX, monocrotophos (561 ) + TX, morphothion (1300) + TX, moxidectin (alternative name) [CCN] + TX, naled (567) + TX, NC-184 (compound code) + TX, NC-512 (compound code) + TX, nifluridide (1309) + TX, nikkomycins (alternative name) [CCN] + TX, nitrilacarb (1313) + TX, nitrilacarb 1 : 1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, parathion (615) + TX, permethrin (626) + TX, petroleum oils (alternative name) (628) + TX, phenkapton (1330) + TX, phenthoate (631 ) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosphamidon (639) + TX, phoxim (642) + TX, pirimiphos-methyl (652) + TX, polychloroterpenes (traditional name) (1347) + TX, polynactins (alternative name) (653) + TX, proclonol (1350) + TX, profenofos (662) + TX, promacyl (1354) + TX, propargite (671 ) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothoate (1362) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridaphenthion (701 ) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, quinalphos (71 1 ) + TX, quintiofos (1381 ) + TX, R-1492 (development code) (1382) + TX, RA-17 (development code) (1383) + TX, rotenone (722) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, SI-0009 (compound code) + TX, sophamide (1402) + TX, spirodiclofen (738) + TX, spiromesifen (739) + TX, SSI-121 (development code) (1404) + TX, sulfiram (alternative name) [CCN] + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfur (754) + TX, SZI-121 (development code) (757) + TX, tau- fluvalinate (398) + TX, tebufenpyrad (763) + TX, TEPP (1417) + TX, terbam (alternative name) + TX, tetrachlorvinphos (777) + TX, tetradifon (786) + TX, tetranactin (alternative name) (653) + TX, tetrasul (1425) + TX, thiafenox (alternative name) + TX, thiocarboxime (1431 ) + TX, thiofanox (800) + TX, thiometon (801 ) + TX, thioquinox (1436) + TX, thuringiensin (alternative name) [CCN] + TX, triamiphos (1441 ) + TX, triarathene (1443) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, trichlorfon (824) + TX, trifenofos (1455) + TX, trinactin (alternative name) (653) + TX, vamidothion (847) + TX, vaniliprole [CCN] and YI-5302 (compound code) + TX,

an algicide selected from the group of substances consisting of bethoxazin [CCN] + TX, copper dioctanoate (lUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endothal (295) + TX, fentin (347) + TX, hydrated lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX,

an anthelmintic selected from the group of substances consisting of abamectin (1 ) + TX, crufomate (101 1 ) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin (alternative name) [CCN] + TX, ivermectin (alternative name) [CCN] + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, piperazine [CCN] + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) and thiophanate (1435) + TX,

an avicide selected from the group of substances consisting of chloralose (127) + TX, endrin (1 122) + TX, fenthion (346) + TX, pyridin-4-amine (lUPAC name) (23) and strychnine (745) + TX, a bactericide selected from the group of substances consisting of 1 -hydroxy- 1 /- -pyridine-2- thione (lUPAC name) (1222) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (lUPAC name) (170) + TX, copper hydroxide (lUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophen (232) + TX, dipyrithione (1 105) + TX, dodicin (1 1 12) + TX, fenaminosulf (1 144) + TX, formaldehyde (404) + TX, hydrargaphen (alternative name) [CCN] + TX, kasugamycin (483) + TX, kasugamycin hydrochloride hydrate (483) + TX, nickel bis(dimethyldithiocarbamate) (lUPAC name) (1308) + TX, nitrapyrin (580) + TX, octhilinone (590) + TX, oxolinic acid (606) + TX, oxytetracycline (61 1 ) + TX, potassium hydroxyquinoline sulfate (446) + TX, probenazole (658) + TX, streptomycin (744) + TX, streptomycin sesquisulfate (744) + TX, tecloftalam (766) + TX, and thiomersal (alternative name) [CCN] + TX,

a biological agent selected from the group of substances consisting of Adoxophyes orana GV (alternative name) (12) + TX, Agrobacterium radiobacter (alternative name) (13) + TX, Amblyseius spp. (alternative name) (19) + TX, Anagrapha falcifera NPV (alternative name) (28) + TX, Anagrus atomus (alternative name) (29) + TX, Aphelinus abdominalis (alternative name) (33) + TX, Aphidius colemani (alternative name) (34) + TX, Aphidoletes aphidimyza (alternative name) (35) + TX, Autographa californica NPV (alternative name) (38) + TX, Bacillus firmus (alternative name) (48) + TX, Bacillus sphaericus Neide (scientific name) (49) + TX, Bacillus thuringiensis Berliner (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. aizawai (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. israelensis (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. japonensis (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. kurstaki (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. tenebrionis (scientific name) (51 ) + TX, Beauveria bassiana (alternative name) (53) + TX, Beauveria brongniartii (alternative name) (54) + TX, Chrysoperla carnea (alternative name) (151 ) + TX, Cryptolaemus montrouzieri (alternative name) (178) + TX, Cydia pomonella GV (alternative name) (191 ) + TX, Dacnusa sibirica (alternative name) (212) + TX, Diglyphus isaea (alternative name) (254) + TX, Encarsia formosa (scientific name) (293) + TX, Eretmocerus eremicus (alternative name) (300) + TX, Helicoverpa zea NPV (alternative name) (431 ) + TX, Heterorhabditis bacteriophora and H. megidis (alternative name) (433) + TX, Hippodamia convergens (alternative name) (442) + TX, Leptomastix dactylopii (alternative name) (488) + TX, Macrolophus caliginosus (alternative name) (491 ) + TX, Mamestra brassicae NPV (alternative name) (494) + TX, Metaphycus helvolus (alternative name) (522) + TX, Metarhizium anisopliae var. acridum (scientific name) (523) + TX, Metarhizium anisopliae var. anisopliae (scientific name) (523) + TX, Neodiprion sertifer NPV and N. lecontei NPV (alternative name) (575) + TX, Orius spp. (alternative name) (596) + TX, Paecilomyces fumosoroseus (alternative name) (613) + TX, Phytoseiulus persimilis (alternative name) (644) + TX, Spodoptera exigua multicapsid nuclear polyhedrosis virus (scientific name) (741 ) + TX, Steinemema bibionis (alternative name) (742) + TX, Steinemema carpocapsae (alternative name) (742) + TX, Steinemema feltiae (alternative name) (742) + TX, Steinemema glaseri (alternative name) (742) + TX, Steinemema riobrave (alternative name) (742) + TX, Steinemema riobravis (alternative name) (742) + TX, Steinemema scapterisci (alternative name) (742) + TX, Steinemema spp. (alternative name) (742) + TX, Trichogramma spp. (alternative name) (826) + TX, Typhlodromus occidentalis (alternative name) (844) and Verticillium lecanii (alternative name) (848) + TX,

a soil sterilant selected from the group of substances consisting of iodomethane (lUPAC name) (542) and methyl bromide (537) + TX,

a chemosterilant selected from the group of substances consisting of apholate [CCN] + TX, bisazir (alternative name) [CCN] + TX, busulfan (alternative name) [CCN] + TX, diflubenzuron (250) + TX, dimatif (alternative name) [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methiotepa [CCN] + TX, methyl apholate [CCN] + TX, morzid [CCN] + TX, penfluron (alternative name) [CCN] + TX, tepa [CCN] + TX, thiohempa (alternative name) [CCN] + TX, thiotepa (alternative name) [CCN] + TX, tretamine (alternative name) [CCN] and uredepa (alternative name) [CCN] + TX, an insect pheromone selected from the group of substances consisting of (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol (lUPAC name) (222) + TX, (E)-tridec-4-en-1-yl acetate (lUPAC name) (829) + TX, (E)-6-methylhept-2-en-4-ol (lUPAC name) (541 ) + TX, (E,Z)-tetradeca-4, 10-dien-1-yl acetate (lUPAC name) (779) + TX, (Z)-dodec-7-en-1-yl acetate (lUPAC name) (285) + TX, (Z)- hexadec-1 1-enal (lUPAC name) (436) + TX, (Z)-hexadec-l 1-en-1-yl acetate (lUPAC name) (437) + TX, (Z)-hexadec-13-en-1 1-yn-1-yl acetate (lUPAC name) (438) + TX, (Z)-icos-13-en-10-one (lUPAC name) (448) + TX, (Z)-tetradec-7-en-1-al (lUPAC name) (782) + TX, (Z)-tetradec-9-en-1-ol (lUPAC name) (783) + TX, (Z)-tetradec-9-en-1-yl acetate (lUPAC name) (784) + TX, (7E,9Z)-dodeca-7,9-dien- 1-yl acetate (lUPAC name) (283) + TX, (9Z, 1 1 E)-tetradeca-9, 1 1-dien-1-yl acetate (lUPAC name) (780) + TX, (9Z, 12E)-tetradeca-9, 12-dien-1-yl acetate (lUPAC name) (781 ) + TX, 14-methyloctadec-1-ene (lUPAC name) (545) + TX, 4-methylnonan-5-ol with 4-methylnonan-5-one (lUPAC name) (544) + TX, alpha-multistriatin (alternative name) [CCN] + TX, brevicomin (alternative name) [CCN] + TX, codlelure (alternative name) [CCN] + TX, codlemone (alternative name) (167) + TX, cuelure (alternative name) (179) + TX, disparlure (277) + TX, dodec-8-en-1-yl acetate (lUPAC name) (286) + TX, dodec-9-en-1-yl acetate (lUPAC name) (287) + TX, dodeca-8 + TX, 10-dien-1-yl acetate (lUPAC name) (284) + TX, dominicalure (alternative name) [CCN] + TX, ethyl 4-methyloctanoate (lUPAC name) (317) + TX, eugenol (alternative name) [CCN] + TX, frontalin (alternative name) [CCN] + TX, gossyplure (alternative name) (420) + TX, grandlure (421 ) + TX, grandlure I (alternative name) (421 ) + TX, grandlure II (alternative name) (421 ) + TX, grandlure III (alternative name) (421 ) + TX, grandlure IV (alternative name) (421 ) + TX, hexalure [CCN] + TX, ipsdienol (alternative name) [CCN] + TX, ipsenol (alternative name) [CCN] + TX, japonilure (alternative name) (481 ) + TX, lineatin (alternative name) [CCN] + TX, litlure (alternative name) [CCN] + TX, looplure (alternative name) [CCN] + TX, medlure [CCN] + TX, megatomoic acid (alternative name) [CCN] + TX, methyl eugenol (alternative name) (540) + TX, muscalure (563) + TX, octadeca-2, 13-dien-1-yl acetate (lUPAC name) (588) + TX, octadeca- 3, 13-dien-1-yl acetate (lUPAC name) (589) + TX, orfralure (alternative name) [CCN] + TX, oryctalure (alternative name) (317) + TX, ostramone (alternative name) [CCN] + TX, siglure [CCN] + TX, sordidin (alternative name) (736) + TX, sulcatol (alternative name) [CCN] + TX, tetradec-1 1-en-1-yl acetate (lUPAC name) (785) + TX, trimedlure (839) + TX, trimedlure A (alternative name) (839) + TX, trimedlure B-i (alternative name) (839) + TX, trimedlure B₂ (alternative name) (839) + TX, trimedlure C (alternative name) (839) and trunc-call (alternative name) [CCN] + TX,

an insect repellent selected from the group of substances consisting of 2-(octylthio)ethanol (lUPAC name) (591 ) + TX, butopyronoxyl (933) + TX, butoxy(polypropylene glycol) (936) + TX, dibutyl adipate (lUPAC name) (1046) + TX, dibutyl phthalate (1047) + TX, dibutyl succinate (lUPAC name) (1048) + TX, diethyltoluamide [CCN] + TX, dimethyl carbate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethyl hexanediol (1 137) + TX, hexamide [CCN] + TX, methoquin-butyl (1276) + TX, methylneodecanamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX,

an insecticide selected from the group of substances consisting of 1-dichloro-1-nitroethane

(lUPAC/Chemical Abstracts name) (1058) + TX, 1 ,1-dichloro-2,2-bis(4-ethylphenyl)ethane (lUPAC name) (1056), + TX, 1 ,2-dichloropropane (lUPAC/Chemical Abstracts name) (1062) + TX, 1 ,2- dichloropropane with 1 ,3-dichloropropene (lUPAC name) (1063) + TX, 1-bromo-2-chloroethane (lUPAC/Chemical Abstracts name) (916) + TX, 2,2,2-trichloro-1-(3,4-dichlorophenyl)ethyl acetate (lUPAC name) (1451 ) + TX, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate (lUPAC name) (1066) + TX, 2-(1 ,3-dithiolan-2-yl)phenyl dimethylcarbamate (lUPAC/ Chemical Abstracts name) (1 109) + TX, 2-(2-butoxyethoxy)ethyl thiocyanate (lUPAC/Chemical Abstracts name) (935) + TX, 2- (4,5-dimethyl-1 ,3-dioxolan-2-yl)phenyl methylcarbamate (lUPAC/ Chemical Abstracts name) (1084) + TX, 2-(4-chloro-3,5-xylyloxy)ethanol (lUPAC name) (986) + TX, 2-chlorovinyl diethyl phosphate (lUPAC name) (984) + TX, 2-imidazolidone (lUPAC name) (1225) + TX, 2-isovalerylindan-1 ,3-dione (lUPAC name) (1246) + TX, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate (lUPAC name) (1284) + TX, 2-thiocyanatoethyl laurate (lUPAC name) (1433) + TX, 3-bromo-1-chloroprop-1-ene (lUPAC name) (917) + TX, 3-methyl-1-phenylpyrazol-5-yl dimethylcarbamate (lUPAC name) (1283) + TX, 4-methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate (lUPAC name) (1285) + TX, 5,5-dimethyl- 3-oxocyclohex-1-enyl dimethylcarbamate (lUPAC name) (1085) + TX, abamectin (1 ) + TX, acephate (2) + TX, acetamiprid (4) + TX, acethion (alternative name) [CCN] + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, acrylonitrile (lUPAC name) (861 ) + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, aldrin (864) + TX, allethrin (17) + TX, allosamidin (alternative name) [CCN] + TX, allyxycarb (866) + TX, alpha-cypermethrin (202) + TX, alpha-ecdysone (alternative name) [CCN] + TX, aluminium phosphide (640) + TX, amidithion (870) + TX, amidothioate (872) + TX, aminocarb (873) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, anabasine (877) + TX, athidathion (883) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azadirachtin (alternative name) (41 ) + TX, azamethiphos (42) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azothoate (889) + TX, Bacillus thuringiensis delta endotoxins (alternative name) (52) + TX, barium hexafluorosilicate (alternative name) [CCN] + TX, barium polysulfide (lUPAC/Chemical Abstracts name) (892) + TX, barthrin [CCN] + TX, Bayer 22/190 (development code) (893) + TX, Bayer 22408 (development code) (894) + TX, bendiocarb (58) + TX, benfuracarb (60) + TX, bensultap (66) + TX, beta-cyfluthrin (194) + TX, beta-cypermethrin (203) + TX, bifenthrin (76) + TX, bioallethrin (78) + TX, bioallethrin S-cyclopentenyl isomer (alternative name) (79) + TX, bioethanomethrin [CCN] + TX, biopermethrin (908) + TX, bioresmethrin (80) + TX, bis(2-chloroethyl) ether (lUPAC name) (909) + TX, bistrifluron (83) + TX, borax (86) + TX, brofenvalerate (alternative name) + TX, bromfenvinfos (914) + TX, bromocyclen (918) + TX, bromo-DDT (alternative name) [CCN] + TX, bromophos (920) + TX, bromophos-ethyl (921 ) + TX, bufencarb (924) + TX, buprofezin (99) + TX, butacarb (926) + TX, butathiofos (927) + TX, butocarboxim (103) + TX, butonate (932) + TX, butoxycarboxim (104) + TX, butylpyridaben (alternative name) + TX, cadusafos (109) + TX, calcium arsenate [CCN] + TX, calcium cyanide (444) + TX, calcium polysulfide (lUPAC name) (1 1 1 ) + TX, camphechlor (941 ) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbon disulfide (lUPAC/Chemical Abstracts name) (945) + TX, carbon tetrachloride (lUPAC name) (946) + TX, carbophenothion (947) + TX, carbosulfan (1 19) + TX, cartap (123) + TX, cartap hydrochloride (123) + TX, cevadine (alternative name) (725) + TX, chlorbicyclen (960) + TX, chlordane (128) + TX, chlordecone (963) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorethoxyfos (129) + TX, chlorfenapyr (130) + TX, chlorfenvinphos (131 ) + TX, chlorfluazuron (132) + TX, chlormephos (136) + TX, chloroform [CCN] + TX, chloropicrin (141 ) + TX, chlorphoxim (989) + TX, chlorprazophos (990) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, chromafenozide (150) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, cis-resmethrin (alternative name) + TX, cismethrin (80) + TX, clocythrin (alternative name) + TX, cloethocarb (999) + TX, closantel (alternative name) [CCN] + TX, clothianidin (165) + TX, copper acetoarsenite [CCN] + TX, copper arsenate [CCN] + TX, copper oleate [CCN] + TX, coumaphos (174) + TX, coumithoate (1006) + TX, crotamiton (alternative name) [CCN] + TX, crotoxyphos (1010) + TX, crufomate (101 1 ) + TX, cryolite (alternative name) (177) + TX, CS 708 (development code) (1012) + TX, cyanofenphos (1019) + TX, cyanophos (184) + TX, cyanthoate (1020) + TX, cyclethrin [CCN] + TX, cycloprothrin (188) + TX, cyfluthrin (193) + TX, cyhalothrin (196) + TX, cypermethrin (201 ) + TX, cyphenothrin (206) + TX, cyromazine (209) + TX, cythioate (alternative name) [CCN] + TX, cf-limonene (alternative name) [CCN] + TX, cf-tetramethrin (alternative name) (788) + TX, DAEP (1031 ) + TX, dazomet (216) + TX, DDT (219) + TX, decarbofuran (1034) + TX, deltamethrin (223) + TX, demephion (1037) + TX, demephion-0 (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-0 (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton-S-methylsulphon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diamidafos (1044) + TX, diazinon (227) + TX, dicapthon (1050) + TX, dichlofenthion (1051 ) + TX, dichlorvos (236) + TX, dicliphos (alternative name) + TX, dicresyl (alternative name) [CCN] + TX, dicrotophos (243) + TX, dicyclanil (244) + TX, dieldrin (1070) + TX, diethyl 5-methylpyrazol-3-yl phosphate (lUPAC name) (1076) + TX, diflubenzuron (250) + TX, dilor (alternative name) [CCN] + TX, dimefluthrin [CCN] + TX, dimefox (1081 ) + TX, dimetan (1085) + TX, dimethoate (262) + TX, dimethrin (1083) + TX, dimethylvinphos (265) + TX, dimetilan (1086) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinoprop (1093) + TX, dinosam (1094) + TX, dinoseb (1095) + TX, dinotefuran (271 ) + TX, diofenolan (1099) + TX, dioxabenzofos (1 100) + TX, dioxacarb (1 101 ) + TX, dioxathion (1 102) + TX, disulfoton (278) + TX, dithicrofos (1 108) + TX, DNOC (282) + TX, doramectin (alternative name) [CCN] + TX, DSP (1 1 15) + TX, ecdysterone (alternative name) [CCN] + TX, El 1642 (development code) (1 1 18) + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, EMPC (1 120) + TX, empenthrin (292) + TX, endosulfan (294) + TX, endothion (1 121 ) + TX, endrin (1 122) + TX, EPBP (1 123) + TX, EPN (297) + TX, epofenonane (1 124) + TX, eprinomectin (alternative name) [CCN] + TX, esfenvalerate (302) + TX, etaphos (alternative name) [CCN] + TX, ethiofencarb (308) + TX, ethion (309) + TX, ethiprole (310) + TX, ethoate-methyl (1 134) + TX, ethoprophos (312) + TX, ethyl formate (lUPAC name) [CCN] + TX, ethyl-DDD (alternative name) (1056) + TX, ethylene dibromide (316) + TX, ethylene dichloride (chemical name) (1 136) + TX, ethylene oxide [CCN] + TX, etofenprox (319) + TX, etrimfos (1 142) + TX, EXD (1 143) + TX, famphur (323) + TX, fenamiphos (326) + TX, fenazaflor (1 147) + TX, fenchlorphos (1 148) + TX, fenethacarb (1 149) + TX, fenfluthrin (1 150) + TX, fenitrothion (335) + TX, fenobucarb (336) + TX, fenoxacrim (1 153) + TX, fenoxycarb (340) + TX, fenpirithrin (1 155) + TX, fenpropathrin (342) + TX, fenpyrad (alternative name) + TX, fensulfothion (1 158) + TX, fenthion (346) + TX, fenthion-ethyl [CCN] + TX, fenvalerate (349) + TX, fipronil (354) + TX, flonicamid (358) + TX, flubendiamide (CAS. Reg. No.: 272451-65-7) + TX, flucofuron (1 168) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenerim [CCN] + TX, flufenoxuron (370) + TX, flufenprox (1 171 ) + TX, flumethrin (372) + TX, fluvalinate (1 184) + TX, FMC 1 137 (development code) (1 185) + TX, fonofos (1 191 ) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, fosmethilan (1 194) + TX, fospirate (1 195) + TX, fosthiazate (408) + TX, fosthietan (1 196) + TX, furathiocarb (412) + TX, furethrin (1200) + TX, gamma-cyhalothrin (197) + TX, gamma-HCH (430) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, GY-81 (development code) (423) + TX, halfenprox (424) + TX, halofenozide (425) + TX, HCH (430) + TX, HEOD (1070) + TX, heptachlor (121 1 ) + TX, heptenophos (432) + TX, heterophos [CCN] + TX, hexaflumuron (439) + TX, HHDN (864) + TX, hydramethylnon (443) + TX, hydrogen cyanide (444) + TX, hydroprene (445) + TX, hyquincarb (1223) + TX, imidacloprid (458) + TX, imiprothrin (460) + TX, indoxacarb (465) + TX, iodomethane (lUPAC name) (542) + TX, IPSP (1229) + TX, isazofos (1231 ) + TX, isobenzan (1232) + TX, isocarbophos (alternative name) (473) + TX, isodrin (1235) + TX, isofenphos (1236) + TX, isolane (1237) + TX, isoprocarb (472) + TX, isopropyl 0-(methoxyaminothiophosphoryl)salicylate (lUPAC name) (473) + TX, isoprothiolane (474) + TX, isothioate (1244) + TX, isoxathion (480) + TX, ivermectin (alternative name) [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, juvenile hormone I (alternative name) [CCN] + TX, juvenile hormone II (alternative name) [CCN] + TX, juvenile hormone III (alternative name) [CCN] + TX, kelevan (1249) + TX, kinoprene (484) + TX, lambda-cyhalothrin (198) + TX, lead arsenate [CCN] + TX, lepimectin (CCN) + TX, leptophos (1250) + TX, lindane (430) + TX, lirimfos (1251 ) + TX, lufenuron (490) + TX, lythidathion (1253) + TX, m- cumenyl methylcarbamate (lUPAC name) (1014) + TX, magnesium phosphide (lUPAC name) (640) + TX, malathion (492) + TX, malonoben (1254) + TX, mazidox (1255) + TX, mecarbam (502) + TX, mecarphon (1258) + TX, menazon (1260) + TX, mephosfolan (1261 ) + TX, mercurous chloride (513) + TX, mesulfenfos (1263) + TX, metaflumizone (CCN) + TX, metam (519) + TX, metam-potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methanesulfonyl fluoride (lUPAC/Chemical Abstracts name) (1268) + TX, methidathion (529) + TX, methiocarb (530) + TX, methocrotophos (1273) + TX, methomyl (531 ) + TX, methoprene (532) + TX, methoquin-butyl (1276) + TX, methothrin (alternative name) (533) + TX, methoxychlor (534) + TX, methoxyfenozide (535) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, methylchloroform (alternative name) [CCN] + TX, methylene chloride [CCN] + TX, metofluthrin [CCN] + TX, metolcarb (550) + TX, metoxadiazone (1288) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime (alternative name) [CCN] + TX, mipafox (1293) + TX, mirex (1294) + TX, monocrotophos (561 ) + TX, morphothion (1300) + TX, moxidectin (alternative name) [CCN] + TX, naftalofos (alternative name) [CCN] + TX, naled (567) + TX, naphthalene (lUPAC/Chemical Abstracts name) (1303) + TX, NC-170 (development code) (1306) + TX, NC-184 (compound code) + TX, nicotine (578) + TX, nicotine sulfate (578) + TX, nifluridide (1309) + TX, nitenpyram (579) + TX, nithiazine (131 1 ) + TX, nitrilacarb (1313) + TX, nitrilacarb 1 : 1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, nornicotine (traditional name) (1319) + TX, novaluron (585) + TX, noviflumuron (586) + TX, 0-5- dichloro-4-iodophenyl O-ethyl ethylphosphonothioate (lUPAC name) (1057) + TX, 0,0-diethyl 0-4- methyl-2-oxo-2A -chromen-7-yl phosphorothioate (lUPAC name) (1074) + TX, 0,0-diethyl O-6-methyl- 2-propylpyrimidin-4-yl phosphorothioate (lUPAC name) (1075) + TX, 0,0, 0',Ο'-tetrapropyl dithiopyrophosphate (lUPAC name) (1424) + TX, oleic acid (lUPAC name) (593) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydemeton-methyl (609) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, para-dichlorobenzene [CCN] + TX, parathion (615) + TX, parathion-methyl (616) + TX, penfluron (alternative name) [CCN] + TX, pentachlorophenol (623) + TX, pentachlorophenyl laurate (lUPAC name) (623) + TX, permethrin (626) + TX, petroleum oils (alternative name) (628) + TX, PH 60-38 (development code) (1328) + TX, phenkapton (1330) + TX, phenothrin (630) + TX, phenthoate (631 ) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosnichlor (1339) + TX, phosphamidon (639) + TX, phosphine (lUPAC name) (640) + TX, phoxim (642) + TX, phoxim-methyl (1340) + TX, pirimetaphos (1344) + TX, pirimicarb (651 ) + TX, pirimiphos-ethyl (1345) + TX, pirimiphos-methyl (652) + TX, polychlorodicyclopentadiene isomers (lUPAC name) (1346) + TX, polychloroterpenes (traditional name) (1347) + TX, potassium arsenite [CCN] + TX, potassium thiocyanate [CCN] + TX, prallethrin (655) + TX, precocene I (alternative name) [CCN] + TX, precocene II (alternative name) [CCN] + TX, precocene III (alternative name) [CCN] + TX, primidophos (1349) + TX, profenofos (662) + TX, profluthrin [CCN] + TX, promacyl (1354) + TX, promecarb (1355) + TX, propaphos (1356) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothiofos (686) + TX, prothoate (1362) + TX, protrifenbute [CCN] + TX, pymetrozine (688) + TX, pyraclofos (689) + TX, pyrazophos (693) + TX, pyresmethrin (1367) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridalyl (700) + TX, pyridaphenthion (701 ) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, pyriproxyfen (708) + TX, quassia (alternative name) [CCN] + TX, quinalphos (71 1 ) + TX, quinalphos-methyl (1376) + TX, quinothion (1380) + TX, quintiofos (1381 ) + TX, R-1492 (development code) (1382) + TX, rafoxanide (alternative name) [CCN] + TX, resmethrin (719) + TX, rotenone (722) + TX, RU 15525 (development code) (723) + TX, RU 25475 (development code) (1386) + TX, ryania (alternative name) (1387) + TX, ryanodine (traditional name) (1387) + TX, sabadilla (alternative name) (725) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, SI-0009 (compound code) + TX, SI-0205 (compound code) + TX, SI-0404 (compound code) + TX, SI-0405 (compound code) + TX, silafluofen (728) + TX, SN 72129 (development code) (1397) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoride (lUPAC/Chemical Abstracts name) (1399) + TX, sodium hexafluorosilicate (1400) + TX, sodium pentachlorophenoxide (623) + TX, sodium selenate (lUPAC name) (1401 ) + TX, sodium thiocyanate [CCN] + TX, sophamide (1402) + TX, spinosad (737) + TX, spiromesifen (739) + TX, spirotetrmat (CCN) + TX, sulcofuron (746) + TX, sulcofuron-sodium (746) + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfuryl fluoride (756) + TX, sulprofos (1408) + TX, tar oils (alternative name) (758) + TX, tau-fluvalinate (398) + TX, tazimcarb (1412) + TX, TDE (1414) + TX, tebufenozide (762) + TX, tebufenpyrad (763) + TX, tebupirimfos (764) + TX, teflubenzuron (768) + TX, tefluthrin (769) + TX, temephos (770) + TX, TEPP (1417) + TX, terallethrin (1418) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachloroethane [CCN] + TX, tetrachlorvinphos (777) + TX, tetramethrin (787) + TX, theta-cypermethrin (204) + TX, thiacloprid (791 ) + TX, thiafenox (alternative name) + TX, thiamethoxam (792) + TX, thicrofos (1428) + TX, thiocarboxime (1431 ) + TX, thiocyclam (798) + TX, thiocyclam hydrogen oxalate (798) + TX, thiodicarb (799) + TX, thiofanox (800) + TX, thiometon (801 ) + TX, thionazin (1434) + TX, thiosultap (803) + TX, thiosultap-sodium (803) + TX, thuringiensin (alternative name) [CCN] + TX, tolfenpyrad (809) + TX, tralomethrin (812) + TX, transfluthrin (813) + TX, transpermethrin (1440) + TX, triamiphos (1441 ) + TX, triazamate (818) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, trichlorfon (824) + TX, trichlormetaphos-3 (alternative name) [CCN] + TX, trichloronat (1452) + TX, trifenofos (1455) + TX, triflumuron (835) + TX, trimethacarb (840) + TX, triprene (1459) + TX, vamidothion (847) + TX, vaniliprole [CCN] + TX, veratridine (alternative name) (725) + TX, veratrine (alternative name) (725) + TX, XMC (853) + TX, xylylcarb (854) + TX, YI-5302 (compound code) + TX, zeta-cypermethrin (205) + TX, zetamethrin (alternative name) + TX, zinc phosphide (640) + TX, zolaprofos (1469) and ZXI 8901 (development code) (858) + TX, cyantraniliprole [736994-63-19 + TX, chlorantraniliprole [500008-45-7] + TX, cyenopyrafen [560121-52-0] + TX, cyflumetofen [400882-07-7] + TX, pyrifluquinazon [337458-27-2] + TX, spinetoram [187166-40-1 + 187166-15-0] + TX, spirotetramat [203313-25-1] + TX, sulfoxaflor [946578-00-3] + TX, flufiprole [704886-18-0] + TX, meperfluthrin [915288-13-0] + TX, tetramethylfluthrin [84937-88-2] + TX, triflumezopyrim (disclosed in WO 2012/0921 15) + TX,

a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (lUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, cloethocarb (999) + TX, copper acetoarsenite [CCN] + TX, copper sulfate (172) + TX, fentin (347) + TX, ferric phosphate (lUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide-olamine (576) + TX, pentachlorophenol (623) + TX, sodium pentachlorophenoxide (623) + TX, tazimcarb (1412) + TX, thiodicarb (799) + TX, tributyltin oxide (913) + TX, trifenmorph (1454) + TX, trimethacarb (840) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX, pyriprole [394730-71-3] + TX,

a nematicide selected from the group of substances consisting of AKD-3088 (compound code) + TX, 1 ,2-dibromo-3-chloropropane (lUPAC/Chemical Abstracts name) (1045) + TX, 1 ,2- dichloropropane (lUPAC/ Chemical Abstracts name) (1062) + TX, 1 ,2-dichloropropane with 1 ,3- dichloropropene (lUPAC name) (1063) + TX, 1 ,3-dichloropropene (233) + TX, 3,4- dichlorotetrahydrothiophene 1 , 1-dioxide (lUPAC/Chemical Abstracts name) (1065) + TX, 3-(4- chlorophenyl)-5-methylrhodanine (lUPAC name) (980) + TX, 5-methyl-6-thioxo-1 ,3,5-thiadiazinan-3- ylacetic acid (lUPAC name) (1286) + TX, 6-isopentenylaminopurine (alternative name) (210) + TX, abamectin (1 ) + TX, acetoprole [CCN] + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, AZ 60541 (compound code) + TX, benclothiaz [CCN] + TX, benomyl (62) + TX, butylpyridaben (alternative name) + TX, cadusafos (109) + TX, carbofuran (1 18) + TX, carbon disulfide (945) + TX, carbosulfan (1 19) + TX, chloropicrin (141 ) + TX, chlorpyrifos (145) + TX, cloethocarb (999) + TX, cytokinins (alternative name) (210) + TX, dazomet (216) + TX, DBCP (1045) + TX, DCIP (218) + TX, diamidafos (1044) + TX, dichlofenthion (1051 ) + TX, dicliphos (alternative name) + TX, dimethoate (262) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin (alternative name) [CCN] + TX, ethoprophos (312) + TX, ethylene dibromide (316) + TX, fenamiphos (326) + TX, fenpyrad (alternative name) + TX, fensulfothion (1 158) + TX, fosthiazate (408) + TX, fosthietan (1 196) + TX, furfural (alternative name) [CCN] + TX, GY-81 (development code) (423) + TX, heterophos [CCN] + TX, iodomethane (lUPAC name) (542) + TX, isamidofos (1230) + TX, isazofos (1231 ) + TX, ivermectin (alternative name) [CCN] + TX, kinetin (alternative name) (210) + TX, mecarphon (1258) + TX, metam (519) + TX, metam-potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, Myrothecium verrucaria composition (alternative name) (565) + TX, NC-184 (compound code) + TX, oxamyl (602) + TX, phorate (636) + TX, phosphamidon (639) + TX, phosphocarb [CCN] + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachlorothiophene (lUPAC/ Chemical Abstracts name) (1422) + TX, thiafenox (alternative name) + TX, thionazin (1434) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, xylenols [CCN] + TX, YI-5302 (compound code) and zeatin (alternative name) (210) + TX, fluensulfone [318290-98-1] + TX,

a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX,

a plant activator selected from the group of substances consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutria sachalinensis extract (alternative name) (720) + TX,

a rodenticide selected from the group of substances consisting of 2-isovalerylindan-1 ,3-dione

(lUPAC name) (1246) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, alpha-chlorohydrin [CCN] + TX, aluminium phosphide (640) + TX, antu (880) + TX, arsenous oxide (882) + TX, barium carbonate (891 ) + TX, bisthiosemi (912) + TX, brodifacoum (89) + TX, bromadiolone (91 ) + TX, bromethalin (92) + TX, calcium cyanide (444) + TX, chloralose (127) + TX, chlorophacinone (140) + TX, cholecalciferol (alternative name) (850) + TX, coumachlor (1004) + TX, coumafuryl (1005) + TX, coumatetralyl (175) + TX, crimidine (1009) + TX, difenacoum (246) + TX, difethialone (249) + TX, diphacinone (273) + TX, ergocalciferol (301 ) + TX, flocoumafen (357) + TX, fluoroacetamide (379) + TX, flupropadine (1 183) + TX, flupropadine hydrochloride (1 183) + TX, gamma-HCH (430) + TX, HCH (430) + TX, hydrogen cyanide (444) + TX, iodomethane (lUPAC name) (542) + TX, lindane (430) + TX, magnesium phosphide (lUPAC name) (640) + TX, methyl bromide (537) + TX, norbormide (1318) + TX, phosacetim (1336) + TX, phosphine (lUPAC name) (640) + TX, phosphorus [CCN] + TX, pindone (1341 ) + TX, potassium arsenite [CCN] + TX, pyrinuron (1371 ) + TX, scilliroside (1390) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoro- acetate (735) + TX, strychnine (745) + TX, thallium sulfate [CCN] + TX, warfarin (851 ) and zinc phosphide (640) + TX,

a synergist selected from the group of substances consisting of 2-(2-butoxyethoxy)ethyl piperonylate (lUPAC name) (934) + TX, 5-(1 ,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (lUPAC name) (903) + TX, farnesol with nerolidol (alternative name) (324) + TX, MB-599 (development code) (498) + TX, MGK 264 (development code) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX, propyl isomer (1358) + TX, S421 (development code) (724) + TX, sesamex (1393) + TX, sesasmolin (1394) and sulfoxide (1406) + TX,

an animal repellent selected from the group of substances consisting of anthraquinone (32) + TX, chloralose (127) + TX, copper naphthenate [CCN] + TX, copper oxychloride (171 ) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, methiocarb (530) + TX, pyridin-4-amine (lUPAC name) (23) + TX, thiram (804) + TX, trimethacarb (840) + TX, zinc naphthenate [CCN] and ziram (856) + TX,

a virucide selected from the group of substances consisting of imanin (alternative name) [CCN] and ribavirin (alternative name) [CCN] + TX,

a wound protectant selected from the group of substances consisting of mercuric oxide (512) + TX, octhilinone (590) and thiophanate-methyl (802) + TX,

and biologically active compounds selected from the group consisting of azaconazole (60207- 31-0] + TX, bitertanol [70585-36-3] + TX, bromuconazole [1 16255-48-2] + TX, cyproconazole [94361- 06-5] + TX, difenoconazole [1 19446-68-3] + TX, diniconazole [83657-24-3] + TX, epoxiconazole [106325-08-0] + TX, fenbuconazole [1 14369-43-6] + TX, fluquinconazole [136426-54-5] + TX, flusilazole [85509-19-9] + TX, flutriafol [76674-21-0] + TX, hexaconazole [79983-71-4] + TX, imazalil [35554-44-0] + TX, imibenconazole [86598-92-7] + TX, ipconazole [125225-28-7] + TX, metconazole [1251 16-23-6] + TX, myclobutanil [88671-89-0] + TX, pefurazoate [101903-30-4] + TX, penconazole [66246-88-6] + TX, prothioconazole [178928-70-6] + TX, pyrifenox [88283-41-4] + TX, prochloraz [67747-09-5] + TX, propiconazole [60207-90-1] + TX, simeconazole [149508-90-7] + TX, tebuconazole [107534-96-3] + TX, tetraconazole [1 12281-77-3] + TX, triadimefon [43121-43-3] + TX, triadimenol [55219-65-3] + TX, triflumizole [99387-89-0] + TX, triticonazole [131983-72-7] + TX, ancymidol [12771- 68-5] + TX, fenarimol [60168-88-9] + TX, nuarimol [63284-71-9] + TX, bupirimate [41483-43-6] + TX, dimethirimol [5221-53-4] + TX, ethirimol [23947-60-6] + TX, dodemorph [1593-77-7] + TX, fenpropidine [67306-00-7] + TX, fenpropimorph [67564-91-4] + TX, spiroxamine [1 18134-30-8] + TX, tridemorph [81412-43-3] + TX, cyprodinil [121552-61-2] + TX, mepanipyrim [1 10235-47-7] + TX, pyrimethanil [531 12-28-0] + TX, fenpiclonil [74738-17-3] + TX, fludioxonil [131341-86-1] + TX, benalaxyl [71626-1 1-4] + TX, furalaxyl [57646-30-7] + TX, metalaxyl [57837-19-1] + TX, R-metalaxyl [70630-17-0] + TX, ofurace [58810-48-3] + TX, oxadixyl [77732-09-3] + TX, benomyl [17804-35-2] + TX, carbendazim [10605-21-7] + TX, debacarb [62732-91-6] + TX, fuberidazole [3878-19-1] + TX, thiabendazole [148-79-8] + TX, chlozolinate [84332-86-5] + TX, dichlozoline [24201-58-9] + TX, iprodione [36734-19-7] + TX, myclozoline [54864-61-8] + TX, procymidone [32809-16-8] + TX, vinclozoline [50471-44-8] + TX, boscalid [188425-85-6] + TX, carboxin [5234-68-4] + TX, fenfuram [24691-80-3] + TX, flutolanil [66332-96-5] + TX, mepronil [55814-41-0] + TX, oxycarboxin [5259-88-1] + TX, penthiopyrad [183675-82-3] + TX, thifluzamide [130000-40-7] + TX, guazatine [108173-90-6] + TX, dodine [2439-10-3] [1 12-65-2] (free base) + TX, iminoctadine [13516-27-3] + TX, azoxystrobin [131860-33-8] + TX, dimoxystrobin [149961-52-4] + TX, enestroburin {Proc. BCPC, Int. Congr., Glasgow, 2003, 1 , 93} + TX, fluoxastrobin [361377-29-9] + TX, kresoxim-methyl [143390-89-0] + TX, metominostrobin [133408-50-1] + TX, trifloxystrobin [141517-21-7] + TX, orysastrobin [248593-16-0] + TX, picoxystrobin [1 17428-22-5] + TX, pyraclostrobin [175013-18-0] + TX, ferbam [14484-64-1] + TX, mancozeb [8018-01-7] + TX, maneb [12427-38-2] + TX, metiram [9006-42-2] + TX, propineb [12071- 83-9] + TX, thiram [137-26-8] + TX, zineb [12122-67-7] + TX, ziram [137-30-4] + TX, captafol [2425- 06-1] + TX, captan [133-06-2] + TX, dichlofluanid [1085-98-9] + TX, fluoroimide [41205-21-4] + TX, folpet [133-07-3 ] + TX, tolylfluanid [731-27-1] + TX, bordeaux mixture [801 1-63-0] + TX, copperhydroxid [20427-59-2] + TX, copperoxychlorid [1332-40-7] + TX, coppersulfat [7758-98-7] + TX, copperoxid [1317-39-1] + TX, mancopper [53988-93-5] + TX, oxine-copper [10380-28-6] + TX, dinocap [131-72-6] + TX, nitrothal-isopropyl [10552-74-6] + TX, edifenphos [17109-49-8] + TX, iprobenphos [26087-47-8] + TX, isoprothiolane [50512-35-1] + TX, phosdiphen [36519-00-3] + TX, pyrazophos [13457-18-6] + TX, tolclofos-methyl [57018-04-9] + TX, acibenzolar-S-methyl [135158-54- 2] + TX, anilazine [101-05-3] + TX, benthiavalicarb [413615-35-7] + TX, blasticidin-S [2079-00-7] + TX, chinomethionat [2439-01-2] + TX, chloroneb [2675-77-6] + TX, chlorothalonil [1897-45-6] + TX, cyflufenamid [180409-60-3] + TX, cymoxanil [57966-95-7] + TX, dichlone [117-80-6] + TX, diclocymet [139920-32-4] + TX, diclomezine [62865-36-5] + TX, dicloran [99-30-9] + TX, diethofencarb [87130-20- 9] + TX, dimethomorph [110488-70-5] + TX, SYP-LI90 (Flumorph) [211867-47-9] + TX, dithianon [3347-22-6] + TX, ethaboxam [162650-77-3] + TX, etridiazole [2593-15-9] + TX, famoxadone [131807- 57-37 + TX, fenamidone [161326-34-7] + TX, fenoxanil [115852-48-7] + TX, fentin [668-34-8] + TX, ferimzone [89269-64-7] + TX, fluazinam [79622-59-6] + TX, fluopicolide [2391 10-15-7] + TX, flusulfamide [106917-52-6] + TX, fenhexamid [126833-17-8] + TX, fosetyl-aluminium [39148-24-8] + TX, hymexazol [10004-44-1] + TX, iprovalicarb [140923-17-7] + TX, IKF-916 (Cyazofamid) [120116- 88-3] + TX, kasugamycin [6980-18-3] + TX, methasulfocarb [66952-49-6] + TX, metrafenone [220899- 03-67 + TX, pencycuron [66063-05-6] + TX, phthalide [27355-22-2] + TX, polyoxins [1 1 1 13-80-7] + TX, probenazole [27605-76-1] + TX, propamocarb [25606-41-1] + TX, proquinazid [189278-12-4] + TX, pyroquilon [57369-32-1] + TX, quinoxyfen [124495-18-7] + TX, quintozene [82-68-8] + TX, sulfur [7704-34-9] + TX, tiadinil [223580-51-6] + TX, triazoxide [72459-58-6] + TX, tricyclazole [41814-78-2] + TX, triforine [26644-46-2] + TX, validamycin [37248-47-8] + TX, zoxamide (RH7281 ) [156052-68-5] + TX, mandipropamid [374726-62-2] + TX, isopyrazam [881685-58-1] + TX, sedaxane [874967-67-6] + TX, 3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid (9-dichloromethylene-1 , 2,3,4- tetrahydro-1 ,4-methano-naphthalen-5-yl)-amide (dislosed in WO 2007/048556) + TX, 3-difluoromethyl- 1-methyl-1 H-pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2-yl)-amide (disclosed in WO 2006/087343) + TX, [(3S,4R,4aR,6S,6aS, 12R, 12aS, 12bS)-3-[(cyclopropylcarbonyl)oxy]- 1 ,3,4,4a,5,6,6a, 12,12a, 12b-decahydro-6, 12-dihydroxy-4,6a, 12b-trimethyl-1 1-oxo-9-(3-pyridinyl)- 2/-/, 1 1 Hnaphtho[2 -6]pyrano[3,4-e]pyran-4-yl]methyl-cyclopropanecarboxylate [915972-17-7] + TX and 1 ,3,5-trimethyl-N-(2-methyl-1-oxopro

(trifluoromethyl)ethyl]phenyl]-1 H-pyrazole-4-carboxamide [926914-55-8] + TX.

The references in brackets behind the active ingredients, e.g. [3878-19-1] refer to the Chemical Abstracts Registry number. The above described mixing partners are known. Where the active ingredients are included in "The Pesticide Manual" [The Pesticide Manual - A World Compendium; Thirteenth Edition; Editor: C. D. S. TomLin; The British Crop Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound; for example, the compound "abamectin" is described under entry number (1 ). Where "[CCN]" is added hereinabove to the particular compound, the compound in question is included in the "Compendium of Pesticide Common Names", which is accessible on the internet [A. Wood; Compendium of Pesticide Common Names, Copyright © 1995-2004]; for example, the compound "acetoprole" is described under the internet address http://www.alanwood.net/pesticides/acetoprole.html.

Most of the active ingredients described above are referred to hereinabove by a so-called "common name", the relevant "ISO common name" or another "common name" being used in individual cases. If the designation is not a "common name", the nature of the designation used instead is given in round brackets for the particular compound; in that case, the lUPAC name, the lUPAC/Chemical Abstracts name, a "chemical name", a "traditional name", a "compound name" or a "develoment code" is used or, if neither one of those designations nor a "common name" is used, an "alternative name" is employed. "CAS Reg. No" means the Chemical Abstracts Registry Number.

The active ingredient mixture of the compounds of formula I selected from Tables 1 to 5 (above) or Table 6 (below) with active ingredients described above comprises a compound selected from Tables 1 to 5 (above) or Table 6 (below) and an active ingredient as described above preferably in a mixing ratio of from 100: 1 to 1 :6000, especially from 50: 1 to 1 :50, more especially in a ratio of from 20: 1 to 1 :20, even more especially from 10:1 to 1 : 10, very especially from 5: 1 and 1 :5, special preference being given to a ratio of from 2:1 to 1 :2, and a ratio of from 4:1 to 2: 1 being likewise preferred, above all in a ratio of 1 : 1 , or 5: 1 , or 5:2, or 5:3, or 5:4, or 4: 1 , or 4:2, or 4:3, or 3: 1 , or 3:2, or 2: 1 , or 1 :5, or 2:5, or 3:5, or 4:5, or 1 :4, or 2:4, or 3:4, or 1 :3, or 2:3, or 1 :2, or 1 :600, or 1 :300, or 1 :150, or 1 :35, or 2:35, or 4:35, or 1 :75, or 2:75, or 4:75, or 1 :6000, or 1 :3000, or 1 :1500, or 1 :350, or 2:350, or 4:350, or 1 :750, or 2:750, or 4:750. Those mixing ratios are by weight.

The mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.

The mixtures comprising a compound of formula I selected from Tables 1 to 5 (above) or Table

6 (below) and one or more active ingredients as described above can be applied, for example, in a single "ready-mix" form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a "tank-mix", and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying the compounds of formula I selected from Tables 1 to 5 (above) or Table 6 (below) and the active ingredients as described above is not essential for working the present invention.

The compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides.

The compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries). These processes for the preparation of the compositions and the use of the compounds of formula I for the preparation of these compositions are also a subject of the invention.

The compounds of formula (I), or a pharmaceutical salt thereof, described above may also have an advantageous spectrum of activity for the treatment and/or prevention of microbial infection in an animal. "Animal" can be any animal, for example, insect, mammal, reptile, fish, amphibian, preferably mammal, most preferably human. "Treatment" means the use on an animal which has microbial infection in order to reduce or slow or stop the increase or spread of the infection, or to reduce the infection or to cure the infection. "Prevention" means the use on an animal which has no apparent signs of microbial infection in order to prevent any future infection, or to reduce or slow the increase or spread of any future infection.

According to the present invention there is provided the use of a compound of formula (I) in the manufacture of a medicament for use in the treatment and/or prevention of microbial infection in an animal. There is also provided the use of a compound of formula (I) as a pharmaceutical agent. There is also provided the use of a compound of formula (I) as an antimicrobial agent in the treatment of an animal. According to the present invention there is also provided a pharmaceutical composition comprising as an active ingredient a compound of formula (I), or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable diluent or carrier. This composition can be used for the treatment and/or prevention of antimicrobial infection in an animal. This pharmaceutical composition can be in a form suitable for oral administration, such as tablet, lozenges, hard capsules, aqueous suspensions, oily suspensions, emulsions dispersible powders, dispersible granules, syrups and elixirs. Alternatively this pharmaceutical composition can be in a form suitable for topical application, such as a spray, a cream or lotion. Alternatively this pharmaceutical composition can be in a form suitable for parenteral administration, for example injection. Alternatively this pharmaceutical composition can be in inhalable form, such as an aerosol spray.

The compounds of formula (I) may be effective against various microbial species able to cause a microbial infection in an animal. Examples of such microbial species are those causing Aspergillosis such as Aspergillus fumigatus, A. flavus, A. terms, A. nidulans and A. niger; those causing

Blastomycosis such as Blastomyces dermatitidis; those causing Candidiasis such as Candida albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei and C. lusitaniae; those causing Coccidioidomycosis such as Coccidioides immitis; those causing Cryptococcosis such as

Cryptococcus neoformans; those causing Histoplasmosis such as Histoplasma capsulatum and those causing Zygomycosis such as Absidia corymbifera, Rhizomucor pusillus and Rhizopus arrhizus. Further examples are Fusarium Spp such as Fusarium oxysporum and Fusarium solani and

Scedosporium Spp such as Scedosporium apiospermum and Scedosporium prolificans. Still further examples are Microsporum Spp, Trichophyton Spp, Epidermophyton Spp, Mucor Spp, Sporothorix Spp, Phialophora Spp, Cladosporium Spp, Petriellidium spp, Paracoccidioides Spp and Histoplasma Spp.

Formulation Examples

Wettable powders a) b) c) active ingredient [compound of formula (I)] 25 % 50 % 75 % sodium lignosulfonate 5 % 5 %

sodium lauryl sulfate 3 % - 5 % sodium diisobutylnaphthalenesulfonate - 6 % 10 % phenol polyethylene glycol ether - 2 %

(7-8 mol of ethylene oxide)

highly dispersed silicic acid 5 % 10 % 10 %

Kaolin 62 % 27 %

The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration.

Powders for drv seed treatment a) b) c) active ingredient [compound of formula (I)] 25 % 50 % 75 % light mineral oil 5 % 5 % 5 % highly dispersed silicic acid 5 % 5 % -

Kaolin 65 % 40 % -

Talcum - 20

The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.

Emulsifiable concentrate

active ingredient [compound of formula (I)] 10 %

octylphenol polyethylene glycol ether 3 %

(4-5 mol of ethylene oxide)

calcium dodecylbenzenesulfonate 3 %

castor oil polyglycol ether (35 mol of ethylene oxide) 4 %

Cyclohexanone 30 % xylene mixture 50 %

Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water.

Dusts a) b) c)

Active ingredient [compound of formula (I)] 5 % 6 % 4 % talcum 95 %

Kaolin - 94 %

mineral filler - - 96 %

Ready-for-use dusts are obtained by mixing the active ingredient with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.

Extruder granules

Active ingredient [compound of formula (I)] 15 %

sodium lignosulfonate 2 %

carboxymethylcellulose 1 %

Kaolin 82 %

The active ingredient is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air.

Coated granules

Active ingredient [compound of formula (I)] 8 %

polyethylene glycol (mol. wt. 200) 3 %

Kaolin 89 %

The finely ground active ingredient is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner. Suspension concentrate

active ingredient [compound of formula (I)] 40 %

propylene glycol 10 %

nonylphenol polyethylene glycol ether (15 mol of ethylene oxide) 6 %

Sodium lignosulfonate 10 %

carboxymethylcellulose 1 %

silicone oil (in the form of a 75 % emulsion in water) 1 %

Water 32 %

The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.

Flowable concentrate for seed treatment

active ingredient [compound of formula (I)] 40 %

propylene glycol 5 %

copolymer butanol PO/EO 2 %

tristyrenephenole with 10-20 moles EO 2 %

1 ,2-benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5 %

monoazo-pigment calcium salt 5 %

Silicone oil (in the form of a 75 % emulsion in water) 0.2 %

Water 45.3 %

Slow Release Capsule Suspension

28 parts of a combination of the compound of formula I are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8:1 ). This mixture is emulsified in a mixture of 1.2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51.6 parts of water until the desired particle size is achieved. To this emulsion a mixture of 2.8 parts 1 ,6- diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed.

The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension formulation contains 28% of the active ingredients. The medium capsule diameter is 8-15 microns.

The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.

Synthetic Examples

The following non-limiting Examples illustrate the above-described invention in greater detail without limiting it. Those skilled in the art will promptly recognise appropriate variations from the procedures both as to reactants and as to reaction conditions and techniques. All references mentioned herein are incorporated by reference in their entirety.

Example P1 :

Preparation of: 4-[1-ethyl-7-[(Z)-N-methoxy-C-methyl-carbonimidoyllimidazo[4,5-clpyridin-2-yll-

1 ,2,5-oxadiazol-3-amine a) To 5-bromo-N4-ethyl-pyridine-3,4-diamine (9.0 g, 42 mmol) was added ethyl 2- cyanoacetate (9.4 g, 8.9 mL, 84 mmol) and the solution was stirred for 20 min at 190°C. The crude reaction mixture was concentrated and purified by Isco combiflash Rf using DCM/MeOH as eluent to give 2-(7-bromo-1-ethyl-imidazo[4,5-c]pyridin-2-yl)acetonitrile as a brown solid.

LCMS: 0.55min; method A; [M+H]⁺ = 265

H NMR (400 MHz, CDCI₃) δ ppm 1.51 (t, J=7.3 Hz, 3H), 4.04 (s, 2H), 4.53 (q, J=7.2 Hz, 2H), 8.47 (s, 1 H), 8.92 (s, 1 H)

b) To a solution of 2-(7-bromo-1-ethyl-imidazo[4,5-c]pyridin-2-yl)acetonitrile (4.80 g, 18.1 mmol) in methanol (60 mL) was added portionwise sodium nitrite (2.50 g, 36.2 mmol) followed by HCI (2N; 18.1 mL, 36.2 mmol). The reaction mixture was stirred for 1 h30mins at rt. The reaction mixture was then adjusted to pH 12 with NaOH (2M; 18.1 mL, 36.2 mmol). Hydroxylamine solution (47.8 g, 44.4 mL, 724 mmol) was added, and the mixture was stirred overnight at 90°C. The resulting precipitate was filtered and washed with water to give 4-(7-bromo-1-ethyl-imidazo[4,5-c]pyridin-2-yl)- 1 ,2,5-oxadiazol-3-amine as a yellow powder.

The product was used in the next step without further purification.

LCMS: 0.88min; method A; [M+H]⁺ = 309

H NMR (400 MHz, CDCI₃) δ ppm 1.52 (t, J=7.2 Hz, 3H), 5.07 (q, J=7.2 Hz, 2H), 5.75 (br. s., 2H), 8.53 (s, 1 H), 9.00 (s, 1 H)

c) To a solution of 4-(7-bromo-1-ethyl-imidazo[4,5-c]pyridin-2-yl)-1 ,2,5-oxadiazol-3-amine (4.5 g, 15 mmol) in dry DMF (49 mL) was added tributyl(1-ethoxyvinyl)stannane (5.8 g, 5.4 mL, 16 mmol) followed by PdCI₂(PPh₃)₂ (0.52 g, 0.73 mmol). The reaction mixture was heated at 1 10 °C for 2h30mins. Water was then added and the aqueous phase extracted with AcOEt. The combined organic layers were washed with a NaHC0₃ sat. solution, water and brine, dried over MgS0₄, filtered, concentrated and purified by Isco combiflash Rf using cyclohexane/AcOEt as eluent to give 4-[7-(1- ethoxyvinyl)-1-ethyl-imidazo[4,5-c]pyridin-2-yl]-1 ,2,5-oxadiazol-3-amine as a yellow solid.

LCMS: 0.83; method A; [M+H]⁺ = 301

H NMR (400 MHz, CDCI₃) δ ppm 1.36 (t, J=7.1 Hz, 3H), 1.39 (t, J=7.1 Hz, 3H), 3.96 (q, J=7.0 Hz, 2H), 4.41 (d, J=2.2 Hz, 1 H), 4.52 (d, J=2.3 Hz, 1 H), 4.78 (q, J=7.0 Hz, 2H), 5.81 (br. s., 2H), 8.38 (s, 1 H), 9.06 (s, 1 H)

d) To a solution of 4-[7-(1-ethoxyvinyl)-1-ethyl-imidazo[4,5-c]pyridin-2-yl]-1 ,2,5-oxadiazol-

3-amine (3.69 g, 12.3 mmol) in methanol (37 mL) was added HCI (2M; 36.9 mL, 73.7 mmol). The reaction mixture was stirred for 72h and then concentrated in vacuo. A sat. solution of NaHC0₃ was slowly added until pH 7 was obtained. The resulting mixture was filtered and the solid further washed with water to give 1-[2-(4-amino-1 ,2,5-oxadiazol-3-yl)-1-ethyl-imidazo[4,5-c]pyridin-7-yl]ethanone as a white solid.

The product was used in the next step without further purification.

LCMS: 0.75min; method A; [M+H]⁺ = 273

H NMR (400 MHz, CDCI₃) δ ppm 1.41 (t, J=7.0 Hz, 3H), 2.83 (s, 3H), 5.06 (q, J=7.0 Hz, 2H), 5.86 (br. s., 2H), 8.94 (s, 1 H), 9.27 (s, 1 H) e) To a solution of 1 -[2-(4-amino-1 ,2,5-oxadiazol-3-yl)-1 -ethyl-imidazo[4,5-c]pyridin-7- yl]ethanone (0.100 g, 0.367 mmol) in acetonitrile (2.5 mL) was added O-methylhydroxylamine hydrochloride (0.049 g, 0.59 mmol) followed by PTSA (0.021 g, 0.12 mmol). The reaction mixture was heated at 90°C for 3h. Water was then added and the aqueous layer extracted with AcOEt. The combined organic layers were washed with a sat. solution of NaHC0₃ and water, dried over MgS0₄, filtered, concentrated under reduced pressure and purified by Isco combiflash Rf using DCM/MeOH as eluent and to give a mixture of 4-[1 -ethyl-7-[(Z)-N-methoxy-C-methyl-carbonimidoyl]imidazo[4,5- c]pyridin-2-yl]-1 ,2,5-oxadiazol-3-amine and 4-[1 -ethyl-7-[(E)-N-methoxy-C-methyl-carbonimidoyl]- imidazo[4,5-c]pyridin-2-yl]-1 ,2,5-oxadiazol-3-amine as white solid. LCMS: 0.77min and 0.80min;

method A; [M+H]⁺ = 302

Isomer Z: H NMR (400 MHz, CDCI₃) δ ppm 1 .38 (t, J=7.2 Hz, 3H), 2.41 (s, 3H), 3.82 (s, 3H), 4.51 (dq, J=14.6, 7.1 Hz, 1 H), 4.87 (dq, J=14.6, 7.2 Hz, 1 H), 5.87 (br. s. , 2H), 8.25 (s, 1 H), 9.13 (s, 1 H)

Isomer E: H NMR (400 MHz, CDCI₃) δ ppm 1 .39 (t, J=7.2 Hz, 3H), 2.41 (s, 3H), 4.05 (s, 3H), 4.91 (q, J=7.0 Hz, 2H), 5.87 (br. s., 2H), 8.43 (s, 1 H), 9.14 (s, 1 H)

The compounds shown in Table 6 were prepared using similar methods.

Table 6: Physical data of compounds of formula (I):

LC-MS method used

Method A

ZQ Mass Spectrometer from Waters (Single quadrupole mass spectrometer)

Instrument Parameters:

lonisation method: Electrospray

Polarity: positive and negative ions

Capillary (kV) 3.00, Cone (V) 30.00, Extractor (V) 2.00, Source Temperature (°C) 150, Desolvation Temperature (°C) 250, Cone Gas Flow (L/Hr) 50, Desolvation Gas Flow (L/Hr) 400Mass range: 100 to 900 Da

HP 1 100 HPLC from Agilent:

Solvent degasser, binary pump, heated column compartment and diode-array detector.

Column: Phenomenex Gemini C18, 3 μιτι, 30 x 3 mm

Temperature: 60 °C

DAD Wavelength range (nm): 210 to 500

Solvent Gradient:

A = water + 5% MeOH + 0.05 % HCOOH

B= Acetonitrile + 0.05 % HCOOH

Time A% B% Flow (mL/min)

0.00 100 0 1.700

2.00 0 100 1.700

2.80 0 100 1.700

2.90 100 0 1.700

3.00 100 0 1.700 Biological Examples:

Alternaria solani I tomato / leaf disc (early blight)

Tomato leaf disks cv. Baby are placed on agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 2 days after application. The inoculated leaf disks are incubated at 23 °C / 21 °C (day/night) and 80% rh under a light regime of 12/12 h (light/dark) in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears on untreated check disk leaf disks (5 - 7 days after application). The following compounds gave at least 80% control of Alternaria solani at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

22 , 37

Botryotinia fuckeliana (Botrytis cinerea) I liquid culture (Gray mould)

Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (Vogels broth).

After placing a DMSO solution of test compound into a 96-well microtiter plate at an application rate of 200ppm, the nutrient broth containing the fungal spores was added. The test plates were incubated at 24°C and the inhibition of growth was determined photometrically 3-4 days after application.

The following compounds gave at least 80% control of Botryotinia fuckeliana at 20 ppm when compared to untreated control under the same conditions, which show extensive disease

development:

1 , 3 , 5 , 7 , 9 , 10 , 11 , 20 , 21 , 22 , 23 , 25 , 27 , 29 , 34 , 36 , 37

Glomerella lagenarium (Colletotrichum lagenarium) I liquid culture (Anthracnose)

Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 °C and the inhibition of growth is measured photometrically 3-4 days after application.

The following compounds gave at least 80% control of Glomerella lagenarium at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

5 , 9 , 10 , 11 , 13 , 20 , 21 , 22 , 23 , 25 , 34 , 36 , 37

Blumeria graminis f. sp. tritici (Erysiphe graminis f. sp. tritici) I wheat / leaf disc preventative (Powdery mildew on wheat)

Wheat leaf segments cv. Kanzler are placed on agar in a multiwell plate (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated by shaking powdery mildew infected plants above the test plates 1 day after application. The inoculated leaf disks are incubated at 20 °C and 60% rh under a light regime of 24 h darkness followed by 12 h light / 12 h darkness in a climate chamber and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears on untreated check leaf segments (6 - 8 days after application).

The following compounds gave at least 80% control of Blumeria graminis f. sp. tritici at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

23 Fusarium culmorum I liquid culture (Head blight)

Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 3-4 days after application.

The following compounds gave at least 80% control of Fusarium culmorum at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

5 , 21 , 23 , 25

Gaeumannomyces graminis I liquid culture (Take-all of cereals)

Mycelial fragments of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96- well format), the nutrient broth containing the fungal spores iss added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 4-5 days after application.

The following compounds gave at least 80% control of Gaeumannomyces graminis at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

5 , 9 , 10 , 11 , 12 , 13 , 14 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 32

Phaeosphaeria nodorum (Septoria nodorum) I wheat / leaf disc preventative (Glume blotch) Wheat leaf segments cv. Kanzler are placed on agar in a multiwell plate (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 2 days after application. The inoculated test leaf disks are incubated at 20 °C and 75% rh under a light regime of 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (5 - 7 days after application).

The following compounds gave at least 80% control of Phaeosphaeria nodorum at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

5 , 9 , 21 , 22 , 23 , 37

Monographella nivalis (Microdochium nivale) I liquid culture (foot rot cereals)

Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 4-5 days after application.

The following compounds gave at least 80% control of Monographella nivalis at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

5 , 9 , 10 , 11 , 13 , 14 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 25 , 28 , 29 , 30 , 32 , 34 , 36 , 37 , 38 Mycosphaerella arachidis (Cercospora arachidicola) I liquid culture (early leaf spot) Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 4-5 days after application.

The following compounds gave at least 80% control of Mycosphaerella arachidis at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

5 , 9 , 10 , 11 , 23 , 35 , 37

Phytophthora infestans I tomato / leaf disc preventative (late blight)

Tomato leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 1 day after application. The inoculated leaf disks are incubated at 16 °C and 75% rh under a light regime of 24 h darkness followed by 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (5 - 7 days after application).

The following compounds gave at least 80% control of Phytophthora infestans at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

5

Plasmopara viticola I grape / leaf disc preventative (late blight)

Grape vine leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 1 day after application. The inoculated leaf disks are incubated at 19 °C and 80% rh under a light regime of 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (6 - 8 days after application).

The following compounds gave at least 80% control of Plasmopara viticola at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

3 , 5 , 7 , 11 , 25 , 29 , 31 , 33 , 35 , 36 , 37

Pythium ultimum I liquid culture (seedling damping off)

Mycelia fragments and oospores of a newly grown liquid culture of the fungus are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal mycelia/spore mixture is added. The test plates are incubated at 24 °C and the inhibition of growth is determined

photometrically 2-3 days after application.

The following compounds gave at least 50% control of Pythium ultimum at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: 5 , 9 , 10 , 16

Puccinia recondita f. sp. tritici I wheat / leaf disc preventative (Brown rust)

Wheat leaf segments cv. Kanzler are placed on agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 1 day after application. The inoculated leaf segments are incubated at 19 °C and 75% rh under a light regime of 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf segments (7 - 9 days after application).

The following compounds gave at least 80% control of Puccinia recondita f. sp. tritici at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

3 , 5 , 6 , 7 , 9 , 10 , 11 , 12 , 20 , 21 , 22 , 23 , 25 , 27 , 29 , 35 , 37 Pyrenophora teres I barley / leaf disc preventative (Net blotch)

Barley leaf segments cv. Hasso are placed on agar in a multiwell plate (24-well format) and sprayed with the formulated test compound diluted in water. The leaf segmens are inoculated with a spore suspension of the fungus 2 days after application. The inoculated leaf segments are incubated at 20 °C and 65% rh under a light regime of 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf segments (5 - 7 days after application).

The following compounds gave at least 80% control of Pyrenophora teres at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

3 , 5 , 6 , 7 , 9 , 10 , 11 , 12 , 18 , 20 , 21 , 22 , 23 , 25 , 26 , 27 , 29 , 31 , 33 , 35 , 36 , 37 , 38

Thanatephorus cucumeris (Rhizoctonia solani) I liquid culture (foot rot, dam ping-off)

Mycelia fragments of a newly grown liquid culture of the fungus are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of the test compounds into a microtiter plate (96-well format), the nutrient broth containing the fungal material is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 3-4 days after application.

The following compounds gave at least 80% control of Thanatephorus cucumeris at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

1 , 3 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 16 , 20 , 21 , 22 , 23 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 35 , 36 , 37 , 38 Sclerotinia sclerotiorum I liquid culture (cottony rot)

Mycelia fragments of a newly grown liquid culture of the fungus are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format) the nutrient broth containing the fungal material is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 3-4 days after application. The following compounds gave at least 80% control of Sclerotinia sclerotiorum at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

5 , 7 , 9 , 10 , 1 1 , 20 , 21 , 23 , 25 , 36 , 37 Mycosphaerella graminicola (Septoria tritici) I liquid culture (Septoria blotch)

The following compounds gave at least 80% control of Mycosphaerella graminicola at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

1 , 3 , 5 , 6 , 7 , 8 , 9 , 10 , 1 1 , 12 , 13 , 14 , 16 , 17 , 20 , 21 , 22 , 23 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 35 , 36 , 37 , 38

Claims

1. A compound of the formula (I)

wherein

Y represents Ci-C₆ alkyl, C₃-C₈ cycloalkyi, C₂-C₆ alkenyl, C₃-C₆ alkynyl or OR¹, wherein the alkyl, cycloalkyi, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹, C_rC₄ alkyl, C C₄ haloalkyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, C1-C4 alkylsulphinyl and C1-C4 alkylsulphonyl;

Y² represents hydrogen, Ci-C₆ alkyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C0₂R¹, CON(R³)₂, phenyl, 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, Ci-C₆ alkyl substituted by phenyl, Ci-C₆ alkyl substituted by 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, OR¹, Ci-C₆ alkylthio, N(R³)₂ or NR³COR², wherein the alkyl, cycloalkyi, cycloalkenyl, alkenyl, alkynyl, phenyl, and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹, C C₄ alkyl, C C₄ haloalkyl, C C₄ alkylthio, C C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y³ represents hydrogen, Ci-C₆ alkyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, phenyl, naphthyl, 5- to 10- membered mono- or bicyclic heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, Ci-C₆ alkyl substituted by phenyl, Ci-C₆ alkyl substituted by 5- or 10- membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated , C0₂R¹, COR² or CON(R³)₂, wherein the alkyl , cycloalkyi, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl, naphthyl, and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², SH, N0₂, OR¹, C C₄ alkyl, C C₄ haloalkyl, phenyl, halophenyl, C C₄ alkylphenyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y⁴ represents hydrogen, halogen, CN, Ci-C₆ alkyl, C₃-C₈ cycloalkyi, C₂-C₆ alkenyl, C₃-C₆ alkynyl, Ci-C₆ alkylthio, OR¹, C0₂R¹ or CON(R³)₂, wherein the alkyl, cycloalkyi, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹, d-C₄ alkyl, C C₄ haloalkyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl, C C₄ alkylthio, C C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl; Y⁵ represents hydrogen, halogen, CN, Ci-C₆ alkyl, C₃-C₈ cycloalkyl, C₂-C₆ alkenyl, C₃-C₆ alkynyl, Ci-C₆ alkylthio, OR¹, C0₂R¹ or CON(R³)₂, wherein the alkyl, cycloalkyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹, C1-C4 alkyl, C_rC₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C_rC₄ alkylthio, C C₄ alkylsulphinyl and C1-C4 alkylsulphonyl;

each R is independently selected from hydrogen, Ci-C₆ alkyl, C₃-C₈ cycloalkyl, Ci-C₂ alkyl substituted by C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, phenyl, benzyl, a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R³) and Ci-C₂ alkyl substituted by a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R³), wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, Ci-C₄-alkoxy-Ci-C₄-alkyl and C1-C4 alkoxycarbonyl;

each R² is independently selected from hydrogen, Ci-C₆ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₈ alkenyl, C₂-C₈ alkynyl, phenyl, benzyl and pyridyl, wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and pyridyl groups are optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 alkylthio and C1-C4 haloalkoxy;

each R³ is independently selected from hydrogen, Ci-C₆ alkyl, C₃-C₆ alkenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₆ alkynyl, phenyl, benzyl, CN, OR¹, COR², Ci-C₆ alkylsulphonyl and a 5- or 6- membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R⁸), wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, C1-C4 alkyl, Ci-C₄-haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy and Ci-C₄-alkoxy-Ci-C₄-alkyl;

wherein when two radicals R³ are attached to the same nitrogen atom, both of these radicals cannot be OR¹;

and wherein when two radicals R³ are attached to the same nitrogen atom, these two radicals together with the nitrogen atom to which they are attached may form a heterocycle, wherein the heterocycle formed is optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy and C1-C4 haloalkoxy;

each R⁸ is independently selected from hydrogen, Ci-C₆ alkyl, Ci-C₆ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl and Ci-C₆ alkoxy-Ci-C₆ alkyl;

or agriculturally acceptable tautomers, salts or N-oxides thereof.

2. A compound according to claim 1 wherein Y represents Ci-C₆ alkyl, C₂-C₆ alkenyl, C₃-C₆ alkynyl or OR¹, wherein the alkyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, NR³COR², OR¹, C_rC₄ alkyl, C_rC₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C1-C4 alkylthio, C1-C4 alkylsulphinyl and C1-C4 alkylsulphonyl; Y² represents hydrogen, Ci-C₆ alkyi, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C0₂R¹, CON(R³)₂, OR¹, d-C₆ alkylthio, N(R³)₂ or NR³COR², wherein the alkyi, cycloalkyl, cycloalkenyl, alkenyl and alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹, d-d alkyi, d-d haloalkyl, d-d alkylthio, d- alkylsulphinyl and d-d alkylsulphonyl;

Y³ represents hydrogen, d-d alkyi, - cycloalkyl, d-d cycloalkenyl, d-d alkenyl, d-d alkynyl, phenyl, 5- to 10-membered mono- or bicyclic heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, d-d alkyi substituted by phenyl, d-d alkyi substituted by 5- or 10-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, C0₂R¹, COR² or CON(R³)₂, wherein the alkyi, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², SH, N0₂, OR¹, d-C₄ alkyi, Ci-C₄ haloalkyl, phenyl, halophenyl, Ci-C₄ alkylphenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d- C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y⁴ represents hydrogen, halogen, CN, d-d alkyi, d-d alkylthio, OR¹, C0₂R¹ or CON(R³)₂, wherein the alkyi is optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹, d-C₄ alkyi, d-C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d-C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y⁵ represents hydrogen, halogen, CN, d-C₄ alkyi, d-C₄ alkylthio, OR¹, C0₂R¹ or CON(R³)₂, wherein the alkyi is optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹, d-C₄ alkyi, d-C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d-C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

each R is independently selected from hydrogen, d-C₆ alkyi, C₃-C₈ cycloalkyl, Ci-C₂ alkyi substituted by C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, phenyl, benzyl, a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R³), or Ci-C₂ alkyi substituted by a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S, N and N(R³), wherein the alkyi, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, Ci-C₄ alkyi, Ci-C₄ haloalkyl, Ci-C₄ alkoxy, Ci-C₄ haloalkoxy, Ci-C₄-alkoxy-Ci-C₄-alkyl and Ci-C₄ alkoxycarbonyl;

each R² is independently selected from the group of hydrogen, Ci-C₈ alkyi, C₃-C₈ cycloalkyl, C₃- C₈ cycloalkenyl, C₂-C₈ alkenyl, C₂-C₈ alkynyl and benzyl wherein the alkyi, cycloalkyl, cycloalkenyl, alkenyl, alkynyl and benzyl are optionally substituted by one or more groups independently selected from halogen, CN, NH₂, N0₂, OH, d-C₄ alkyi, d-C₄ haloalkyl, d-C₄ alkoxy and d-C₄ haloalkoxy; each R³ independently of one another represents hydrogen, Ci-C₈ alkyi, C₃-C₈ cycloalkyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl or COR²; wherein when two radicals R³ are attached to the same nitrogen atom, these radicals can be identical or different; and wherein when two radicals R³ are attached to the same nitrogen atom, these two radicals together with the nitrogen atom to which they are attached may form a morpholine, piperidine, piperazine, imidazole, pyrazole or triazole; wherein the cycle formed is optionally substituted by one or more groups independently selected from halogen, methyl, methoxy and halomethyl.

3. A compound according to either claim 1 or claim 2 wherein Y represents Ci-C₆ alkyl, C₂-C₆ alkenyl, C₃-C₆ alkynyl or OR¹, wherein the alkyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, Ci-C₄ alkyl, Ci-C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃- C₈ cycloalkenyl and Ci-C₄ alkylthio;

Y² represents Ci-C₆ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C0₂R¹, CON(R³)₂, OR¹, Ci-Ce alkylthio, N(R³)₂ or NR³COR², wherein the alkyl, cycloalkyl,

cycloalkenyl, alkenyl, alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OR¹, C_rC₄ alkyl and C_rC₄ haloalkyl;

Y³ represents hydrogen, Ci-C₆ alkyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, phenyl, 5- to 10- membered mono- or bicyclic heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, Ci-C₆ alkyl substituted by phenyl, Ci-C₆ alkyl substituted by 5- or 10-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, C0₂R¹ or CON(R³)₂, wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², SH, N0₂, OR¹, C_rC₄ alkyl, C_rC₄ haloalkyl, phenyl, halophenyl, Ci-C₄ alkylphenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, Ci-C₄

alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y⁴ represents hydrogen, halogen, CN, C C₄ alkyl, C C₄ alkylthio, OR¹, C0₂R¹ or CON(R³)₂, wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹, C C₄ alkyl, C C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

Y⁵ represents hydrogen, halogen, CN, C C₄ alkyl, C C₄ alkylthio, OR¹, C0₂R¹ or CON(R³)₂, wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, NR³COR², OR¹, C C₄ alkyl, C C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

each R is independently selected from hydrogen, Ci-C₈ alkyl, C₃-C₈ cycloalkyl, Ci-C₂ alkyl substituted by C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, phenyl, benzyl, a 5- or 6-membered heterocycle containing one to two heteroatoms independently selected from O, S and N, or Ci-C₂ alkyl substituted by a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, C C₄ alkyl, C C₄ haloalkyl, C C₄ alkoxy, C C₄ haloalkoxy and Ci-C₄ alkoxycarbonyl;

each R² independently of one another represents hydrogen, Ci-C₈ alkyl or Ci-C₈ haloalkyl; each R³ independently of one another represents hydrogen, Ci-C₄ alkyl, C₃-C₄ alkenyl, C₃-C₄ alkynyl or COR²; wherein when two radicals R³ are attached to the same nitrogen atom, these radicals can be identical or different; and wherein when two radicals R³ are attached to the same nitrogen atom, these two radicals together with the nitrogen atom to which they are attached may form a morpholine, piperidine, piperazine, imidazole, pyrazole or triazole, wherein the cycle formed is optionally substituted by one or more groups independently selected from halogen, methyl, methoxy and halomethyl.

4. A compound according to any preceding claim wherein Y represents Ci-C₆ alkyl or OR¹ , wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, C1-C4 alkyl, C1-C4 haloalkyl, C₃-C₈ cycloalkyl and C₃-C₈ cycloalkenyl;

Y² represents Ci-C₆ alkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₂-C₆ alkenyl or C₂-C₆ alkynyl wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl and alkynyl are optionally substituted by one or more groups independently selected from halogen, CN, OR¹ , C1-C4 alkyl and C1-C4 haloalkyl;

Y³ represents Ci-C₆ alkyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, phenyl, 5- to 10- membered mono- or bicyclic heterocycle containing one to three heteroatoms independently selected from O, S and N, , wherein the heterocycle can be aromatic, or fully or partially saturated, Ci-C₆ alkyl substituted by phenyl or Ci-C₆ alkyl substituted by 5- or 10-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the heterocycle can be aromatic, or fully or partially saturated, wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN , OH , NH₂, NR³COR², SH, N0₂, OR¹ , d-d alkyl, d-d haloalkyl, phenyl, halophenyl, d-d alkylphenyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C1-C4 alkylthio, C1-C4 alkylsulphinyl and C1-C4 alkylsulphonyl;

Y⁴ represents hydrogen, halogen, CN , Ci-C₂ alkyl, Ci-C₂ alkylthio or OR¹ , wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, CN , OH, NH₂, NR³COR², OR¹ , d-d alkyl, d-d haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d-d alkylthio, d- C₄ alkylsulphinyl and C1-C4 alkylsulphonyl;

Y⁵ represents hydrogen, halogen, CN , Ci-C₂ alkyl, Ci-C₂ alkylthio or OR¹ , wherein the alkyl is optionally substituted by one or more groups independently selected from halogen, CN, OH , NH₂, NR³COR², OR¹ , d-d alkyl, d-C₄ haloalkyl, C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, d-C₄ alkylthio, d- C₄ alkylsulphinyl and C1-C4 alkylsulphonyl;

each R is independently selected from hydrogen, Ci-C₈ alkyl, C₃-C₈ cycloalkyl, Ci-C₂ alkyl substituted by C₃-C₈ cycloalkyl, C₃-C₈ cycloalkenyl, C₃-C₈ alkenyl, C₃-C₈ alkynyl, phenyl, benzyl, a 5- or 6-membered heterocycle containing one to two heteroatoms independently selected from O, S and N, or d-C₂ alkyl substituted by a 5- or 6-membered heterocycle containing one to three heteroatoms independently selected from O, S and N, wherein the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, phenyl, benzyl and heterocycle are optionally substituted by one or more groups independently selected from halogen, CN, OH , NH₂, N0₂, SH, d-C₄ alkyl, d-C₄ haloalkyl, d-C₄ alkoxy, d-C₄ haloalkoxy and C1-C4 alkoxycarbonyl;

each R² independently of one another represents hydrogen, C1-C4 alkyl or C1-C4 haloalkyl; each R³ independently of one another represents hydrogen, Ci-C₈ alkyl or COR².

5. A compound according to any preceding claim wherein Y represents Ci-C₄ alkyl optionally substituted by one or more groups independently selected from halogen, Ci-C₂ alkyl, Ci-C₂ haloalkyi and C₃-C₆ cycloalkyi;

Y² represents Ci-C₆ alkyl or C₃-C₈ cycloalkyi wherein the alkyl and cycloalkyi are optionally substituted by one or more groups independently selected from halogen, CN, OR¹, Ci-C₄ alkyl and d- C₄ haloalkyi;

Y³ represents Ci-C₆ alkyl, C₂-C₆ alkenyl or Ci-C₂-alkyl substituted by phenyl, wherein the alkyl, alkenyl, and phenyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹, C_rC₄ alkyl, C_rC₄ haloalkyi, phenyl, halophenyl, C C₄ alkylphenyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl, Ci-C₄ alkylthio, Ci-C₄ alkylsulphinyl and Ci-C₄ alkylsulphonyl;

each R is independently selected from hydrogen, Ci-C₈ alkyl, C₃-C₆ cycloalkyl-Ci-C₂ alkyl, C₃-

C₆ alkenyl, phenyl, benzyl, pyridyl or pyridyl-Ci-C₂ alkyl wherein the alkyl, cycloalkyi, alkenyl, phenyl, benzyl and pyridyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, C C₄ alkyl, C C₄ haloalkyi, C C₄ alkoxy, C C₄ haloalkoxy and C

C₄ alkoxycarbonyl.

6. A compound according to any preceding claim wherein Y² represents Ci-C₄ alkyl optionally substituted by one or more groups independently selected from halogen, Ci-C₂ alkyl, Ci-C₂ haloalkyi and C₃-C₆ cycloalkyi;

Y³ represents Ci-C₆ alkyl or C₂-C₆ alkenyl, wherein the alkyl and alkenyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹, phenyl, halophenyl, Ci-C₄ alkylphenyl, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl and Ci-C₄ alkylthio;

Y⁴ represents hydrogen, halogen or CN;

Y⁵ represents hydrogen, halogen or CN;

each R is independently selected from hydrogen, Ci-C₈ alkyl, C₃-C₆ cycloalkyl-Ci-C₂ alkyl, C₃- C₆ alkenyl, phenyl, benzyl, pyridyl and pyridyl-Ci-C₂ alkyl wherein the alkyl, cycloalkyi, alkenyl, phenyl, benzyl and pyridyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, C C₄ alkyl, C C₄ haloalkyi, C C₄ alkoxy, C C₄ haloalkoxy and C C₄ alkoxycarbonyl.

7. A compound according to any preceding claim wherein Y³ represents Ci-C₆ alkyl, C₂-C₆ alkenyl, benzyl, halobenzyl, Ci-C₄ alkylbenzyl, wherein the alkyl and alkenyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, SH, N0₂, OR¹, C₃-C₈ cycloalkyi, C₃-C₈ cycloalkenyl and Ci-C₄ alkylthio;

Y⁴ represents hydrogen; Y⁵ represents hydrogen;

each R is independently selected from hydrogen, Ci-C₈ alkyl, C₃-C₆ alkenyl, phenyl, benzyl or pyridyl wherein the alkyl, cycloalkyi, alkenyl, phenyl and pyridyl are optionally substituted by one or more groups independently selected from halogen, CN, OH, NH₂, N0₂, SH, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy and C1-C4 haloalkoxy.

8. A compound according to any preceding claim wherein each R is independently selected from hydrogen, Ci-C₈ alkyl or Ci-C₈ haloalkyl.

9. A composition for controlling microorganisms or for preventing attack and infestation of plants therewith, wherein the active ingredient is a compound of the formula (I) as claimed in any of claims 1- 8, together with a suitable carrier.

10. The composition of claim 10 further comprising an adjuvant.

11. A method of controlling or preventing infestation of cultivated plants by phytopathogenic microorganisms by application of a compound of formula (I) as claimed in any of claims 1-8 to plants, to parts of plants or to the locus thereof.

12. The method of claim 12 wherein the microorganisms are fungal organisms.

13. A compound according to any of claims 1-8 for use as a pharmaceutical agent.

14. A compound according to any of claims 1-8 for use as an antimicrobial agent.